Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:naphthopyran
go back to main search page
Accession:CHEBI:86027 term browser browse the term
Definition:Any organic heterotricyclic compound with a skeleton consisting of a pyran ring ortho-fused to a naphthalene.
Synonyms:related_synonym: naphthopyrans


show annotations for term's descendants           Sort by:
 
alpha-naphthoflavone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 multiple interactions EXP [alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of ADAMTS1 promoter; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of ADAMTS1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ADAMTS1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of ADAMTS1 promoter] CTD PMID:29094188 NCBI chr11:25,342,119...25,350,938
Ensembl chr11:25,342,126...25,350,974
JBrowse link
G Ahr aryl hydrocarbon receptor affects binding
decreases activity
multiple interactions
ISO
EXP
[alpha-naphthoflavone binds to AHR protein] which binds to ESR1 protein; [alpha-naphthoflavone binds to AHR protein] which binds to ESRRA protein; [alpha-naphthoflavone binds to AHR protein] which binds to NR2F1 protein; alpha-naphthoflavone binds to AHR protein
alpha-naphthoflavone results in decreased activity of AHR protein
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK3 protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of STAT5B protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FLG mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Hexachlorobenzene; [alpha-naphthoflavone results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in increased abundance of Reactive Oxygen Species]; alpha-naphthoflavone analog inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone analog results in increased activity of [AHR protein binds to ARNT protein]; alpha-naphthoflavone binds to and results in decreased activity of AHR protein; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[benzo(k)fluoranthene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Oxygen deficiency co-treated with Tetrachlorodibenzodioxin] results in decreased stability of AHR protein]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein]; alpha-naphthoflavone inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]; alpha-naphthoflavone inhibits the reaction [AHR protein binds to and results in increased metabolism of Benzo(a)pyrene]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein]; alpha-naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IL10 protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] results in decreased susceptibility to [SB 203580 results in increased expression of CYP1A1]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Benzo(a)pyrene; alpha-naphthoflavone binds to and results in decreased activity of AHR protein; alpha-naphthoflavone binds to and results in increased activity of AHR protein; alpha-naphthoflavone inhibits the reaction [AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein]
[alpha-naphthoflavone results in decreased activity of AHR protein] which results in decreased expression of CYP1A1 mRNA; AHR gene mutant form inhibits the reaction [alpha-naphthoflavone results in increased expression of IGFBP4 protein]; AHR protein promotes the reaction [alpha-naphthoflavone results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone binds to and results in decreased activity of AHR protein; alpha-naphthoflavone binds to and results in increased activity of AHR protein; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of AHR protein]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to SP1 promoter]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein]; alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of AHR mRNA]
CTD PMID:1329656, PMID:7669069, PMID:8390116, PMID:8738555, PMID:9006915, PMID:10593590, PMID:10620335, PMID:11165043, PMID:11516172, PMID:11577022, PMID:11768231, PMID:12051995, PMID:12093619, PMID:12111005, PMID:12559965, PMID:12644593, PMID:12799773, PMID:14993811, PMID:15019843, PMID:15041469, PMID:15364539, PMID:15459018, PMID:15797623, PMID:16054781, PMID:16359657, PMID:17669606, PMID:17681673, PMID:18072750, PMID:18259752, PMID:19828881, PMID:20187624, PMID:20634293, PMID:21127131, PMID:21205633, PMID:21732638, PMID:21835898, PMID:22975028, PMID:23639626, PMID:24161567, PMID:26519956, PMID:29094188, PMID:29935983 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
increases methylation
EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of AKT1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of AKT1 mRNA]
alpha-naphthoflavone results in increased methylation of AKT1 promoter
CTD PMID:29094188 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
JBrowse link
G Ar androgen receptor multiple interactions
increases expression
ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of AR protein]; alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]
alpha-naphthoflavone results in increased expression of AR protein
CTD PMID:12970580, PMID:15041469 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO alpha-naphthoflavone analog results in increased activity of [AHR protein binds to ARNT protein]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]
ARNT protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]
CTD PMID:11768231, PMID:21127131, PMID:30508555 NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO
EXP
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA]
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of BAX mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of BAX promoter]
CTD PMID:20562217, PMID:29094188 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bmp15 bone morphogenetic protein 15 multiple interactions EXP [Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of BMP15 mRNA CTD PMID:29094188 NCBI chr  X:17,016,831...17,021,894
Ensembl chr  X:17,016,778...17,023,418
JBrowse link
G Bpgm bisphosphoglycerate mutase multiple interactions
increases expression
ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BPGM mRNA]
alpha-naphthoflavone results in increased expression of BPGM mRNA
CTD PMID:23152189 NCBI chr 4:61,912,210...61,940,697
Ensembl chr 4:61,912,210...61,940,696
JBrowse link
G Brca1 BRCA1, DNA repair associated multiple interactions ISO alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein]; alpha-naphthoflavone inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] CTD PMID:16489025, PMID:18259752 NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
JBrowse link
G Calr calreticulin multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CALR mRNA] CTD PMID:29094188 NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
JBrowse link
G Casp12 caspase 12 increases cleavage ISO alpha-naphthoflavone results in increased cleavage of CASP12 protein CTD PMID:30508555 NCBI chr 8:2,658,892...2,686,160
Ensembl chr 8:2,659,865...2,686,160
JBrowse link
G Casp3 caspase 3 increases activity
increases cleavage
decreases activity
ISO
EXP
alpha-naphthoflavone results in increased activity of CASP3 protein
alpha-naphthoflavone results in increased cleavage of CASP3 protein
alpha-naphthoflavone results in decreased activity of CASP3 protein
CTD PMID:15710172, PMID:18334599, PMID:30508555 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casp8 caspase 8 increases activity ISO alpha-naphthoflavone results in increased activity of CASP8 protein CTD PMID:18334599 NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
JBrowse link
G Casp9 caspase 9 increases activity
multiple interactions
ISO
EXP
alpha-naphthoflavone results in increased activity of CASP9 protein
[alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of CASP9 promoter; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CASP9 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CASP9 promoter]
CTD PMID:18334599, PMID:29094188 NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
JBrowse link
G Cat catalase multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein] CTD PMID:20600218 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
JBrowse link
G Ccl1 C-C motif chemokine ligand 1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CCL1] CTD PMID:16679317 NCBI chr10:69,534,976...69,537,836
Ensembl chr10:69,534,933...69,537,882
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression
increases expression
multiple interactions
ISO alpha-naphthoflavone results in decreased expression of CCL2 mRNA
alpha-naphthoflavone results in increased expression of CCL2 mRNA
alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA]
CTD PMID:22262711 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Plant Extracts results in decreased expression of CCNB1 mRNA] CTD PMID:25051199 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
JBrowse link
G Cd9 CD9 molecule multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of CD9 mRNA] CTD PMID:29094188 NCBI chr 4:157,977,163...158,010,091
Ensembl chr 4:157,977,162...158,010,166
JBrowse link
G Cdc25c cell division cycle 25C multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Plant Extracts results in decreased expression of CDC25C mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of CDC25C protein] CTD PMID:22266097, PMID:25051199 NCBI chr18:27,528,768...27,550,316
Ensembl chr18:27,528,354...27,550,224
JBrowse link
G Cdh13 cadherin 13 multiple interactions EXP AHR protein promotes the reaction [alpha-naphthoflavone results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDH13 mRNA] CTD PMID:12559965 NCBI chr19:50,848,793...51,971,618
Ensembl chr19:50,848,736...51,972,103
JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of CDK1 protein] CTD PMID:22266097 NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
decreases methylation
EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased methylation of CDK2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of CDK2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CDK2 mRNA]
alpha-naphthoflavone results in decreased methylation of CDK2 promoter
CTD PMID:29094188 NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene promotes the reaction [eupatorin-5-methyl ether results in increased expression of CDKN1A protein]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CDKN1A mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1A protein] CTD PMID:21887816, PMID:22266097, PMID:23994263, PMID:24361490 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] CTD PMID:15157999, PMID:22266097 NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] CTD PMID:20801209 NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
JBrowse link
G Ctsd cathepsin D multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]] CTD PMID:11165043 NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451
JBrowse link
G Cygb cytoglobin multiple interactions ISO alpha-naphthoflavone inhibits the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYGB mRNA] CTD PMID:25781201 NCBI chr10:105,618,325...105,628,091
Ensembl chr10:105,618,326...105,628,091
JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 multiple interactions
increases expression
ISO alpha-naphthoflavone promotes the reaction [CYP11B1 protein results in increased chemical synthesis of Hydrocortisone]
alpha-naphthoflavone results in increased expression of CYP11B1 mRNA
CTD PMID:22172629 NCBI chr 7:116,248,759...116,255,205
Ensembl chr 7:116,156,219...116,255,167
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 decreases expression ISO alpha-naphthoflavone results in decreased expression of CYP17A1 mRNA CTD PMID:24875446 NCBI chr 1:266,422,127...266,429,947
Ensembl chr 1:266,422,132...266,428,239
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions
increases expression
ISO [alpha-naphthoflavone results in decreased activity of CYP19A1 protein] which results in decreased susceptibility to o,p'-DDT; alpha-naphthoflavone binds to and results in decreased activity of CYP19A1 protein; alpha-naphthoflavone inhibits the reaction [Aflatoxin B1 results in increased expression of CYP19A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 protein]
alpha-naphthoflavone results in increased expression of CYP19A1 protein
CTD PMID:9435150, PMID:20678559, PMID:20823264, PMID:21296134 NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases activity
affects binding
increases expression
multiple interactions
decreases activity
ISO
EXP
alpha-naphthoflavone results in increased activity of CYP1A1 protein
CYP1A1 protein binds to alpha-naphthoflavone
alpha-naphthoflavone results in increased expression of CYP1A1 mRNA
alpha-naphthoflavone analog results in increased expression of CYP1A1 mRNA; alpha-naphthoflavone results in increased expression of CYP1A1 mRNA; alpha-naphthoflavone results in increased expression of CYP1A1 protein
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [[3,4,5,3',4'-pentachlorobiphenyl co-treated with Benzo(a)pyrene] results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[benzo(k)fluoranthene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] which results in increased metabolism of Benzo(a)pyrene]; alpha-naphthoflavone inhibits the reaction [afimoxifene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Calcitriol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Cycloheximide results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Resveratrol results in increased expression of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [STO 609 results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
alpha-naphthoflavone results in decreased activity of CYP1A1 protein
[alpha-naphthoflavone results in decreased activity of AHR protein] which results in decreased expression of CYP1A1 mRNA; [alpha-naphthoflavone results in decreased activity of CYP1A1 protein] inhibits the reaction [Vinyl Compounds analog results in decreased susceptibility to sodium arsenite]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of CYP1A1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CYP1A1 promoter]; alpha-naphthoflavone inhibits the reaction [norisoboldine results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]
[[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] results in decreased susceptibility to [SB 203580 results in increased expression of CYP1A1]; alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of CYP1A1 mRNA]; SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased expression of CYP1A1 mRNA]
alpha-naphthoflavone analog results in increased activity of CYP1A1 protein
CTD PMID:1329656, PMID:6477826, PMID:7669069, PMID:8390116, PMID:8637871, PMID:9169082, PMID:10496962, PMID:11339718, PMID:11516172, PMID:11768231, PMID:12051995, PMID:12093619, PMID:12111005, PMID:12799773, PMID:12859983, PMID:14993811, PMID:15075337, PMID:15276085, PMID:15306208, PMID:15385644, PMID:15456928, PMID:15698582, PMID:15766918, PMID:15893423, PMID:16426572, PMID:16906435, PMID:17069994, PMID:17275222, PMID:17872374, PMID:18308446, PMID:18493746, PMID:18755850, PMID:19244278, PMID:19553035, PMID:19828881, PMID:19901195, PMID:20187624, PMID:20801209, PMID:20816883, PMID:20823264, PMID:21053930, PMID:21127131, PMID:21162728, PMID:21621526, PMID:21732638, PMID:21932800, PMID:22837390, PMID:22975028, PMID:23099484, PMID:24161567, PMID:24361490, PMID:26221077, PMID:27163632, PMID:27393915, PMID:27966929, PMID:29094188, PMID:29274324, PMID:30508555 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
affects binding
increases expression
increases metabolic processing
affects metabolic processing
decreases activity
ISO
EXP
[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; alpha-naphthoflavone binds to and results in decreased activity of CYP1A2 protein; alpha-naphthoflavone inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]; alpha-naphthoflavone inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]; alpha-naphthoflavone inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]
CYP1A2 protein binds to alpha-naphthoflavone
alpha-naphthoflavone results in increased expression of CYP1A2 protein
[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with alpha-naphthoflavone] results in increased expression of CYP1A2 protein; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]
[[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]; [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased reduction of and results in decreased oxidation of 9-anthraldehyde
CYP1A2 protein results in increased metabolism of alpha-naphthoflavone
alpha-naphthoflavone results in increased expression of CYP1A2 mRNA; alpha-naphthoflavone results in increased expression of CYP1A2 protein
CYP1A2 protein affects the metabolism of alpha-naphthoflavone
CTD PMID:2180560, PMID:9305587, PMID:15306208, PMID:15766918, PMID:15860655, PMID:17702393, PMID:18493746, PMID:19828881, PMID:20448087, PMID:20816883, PMID:21053930, PMID:21766881, PMID:21932800, PMID:26599973, PMID:27966929, PMID:28887089, PMID:29074051 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
affects binding
increases metabolic processing
increases expression
decreases expression
decreases activity
ISO
EXP
alpha-naphthoflavone binds to and results in decreased activity of CYP1B1 protein; alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1B1 mRNA]; alpha-naphthoflavone inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1B1 mRNA]; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein co-treated with NADP] results in increased metabolism of 2,4,3',5'-tetramethoxystilbene]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]
CYP1B1 protein binds to alpha-naphthoflavone
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1B1 mRNA]
CYP1B1 protein results in increased metabolism of alpha-naphthoflavone
alpha-naphthoflavone inhibits the reaction [AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]]
alpha-naphthoflavone results in increased expression of CYP1B1 mRNA
alpha-naphthoflavone results in decreased expression of CYP1B1 mRNA
alpha-naphthoflavone results in decreased activity of CYP1B1 protein
CTD PMID:11577022, PMID:15075337, PMID:15280921, PMID:16120791, PMID:19182260, PMID:19563207, PMID:20823264, PMID:21053930, PMID:22262711, PMID:27163632, PMID:27966929, PMID:29146461 NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
JBrowse link
G Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Cycloheximide promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]] CTD PMID:19244278 NCBI chr 3:168,097,484...168,111,920
Ensembl chr 3:168,097,485...168,111,920
JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2C11 mRNA] CTD PMID:18467041 NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
JBrowse link
G Cyp2f4 cytochrome P450, family 2, subfamily f, polypeptide 4 multiple interactions ISO [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] CTD PMID:20187624 NCBI chr 1:83,933,974...83,947,804
Ensembl chr 1:83,933,942...83,947,821
JBrowse link
G Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 decreases activity ISO alpha-naphthoflavone results in decreased activity of CYP2J2 protein CTD PMID:12851038 NCBI chr 5:119,546,458...119,564,843
Ensembl chr 5:119,546,461...119,564,846
JBrowse link
G Dazl deleted in azoospermia-like multiple interactions ISO alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA] CTD PMID:20562217 NCBI chr 9:12,633,983...12,651,017
Ensembl chr 9:12,633,990...12,650,938
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
multiple interactions
ISO alpha-naphthoflavone results in increased expression of DDIT3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; ARNT protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; pyrazolanthrone inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; SB 203580 inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]
CTD PMID:30508555 NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
JBrowse link
G Ddr2 discoidin domain receptor tyrosine kinase 2 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDR2 mRNA] CTD PMID:29094188 NCBI chr13:88,311,639...88,436,561
Ensembl chr13:88,317,145...88,436,789
JBrowse link
G Ddx4 DEAD-box helicase 4 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA] CTD PMID:20562217 NCBI chr 2:44,447,610...44,504,263
Ensembl chr 2:44,447,573...44,504,354
JBrowse link
G Ddx5 DEAD-box helicase 5 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDX5 mRNA] CTD PMID:29094188 NCBI chr10:94,979,759...94,988,461
Ensembl chr10:94,980,928...94,988,461
JBrowse link
G Dll1 delta like canonical Notch ligand 1 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DLL1 mRNA] CTD PMID:29094188 NCBI chr 1:57,318,621...57,326,732
Ensembl chr 1:57,318,708...57,327,379
JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 decreases methylation
multiple interactions
EXP alpha-naphthoflavone results in decreased methylation of DNAJB6 promoter
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of DNAJB6 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DNAJB6 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of DNAJB6 promoter]
CTD PMID:29094188 NCBI chr 4:2,711,329...2,774,969
Ensembl chr 4:2,711,385...2,774,890
JBrowse link
G Dusp5 dual specificity phosphatase 5 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 protein] CTD PMID:19578757 NCBI chr 1:274,245,184...274,258,595
Ensembl chr 1:274,245,184...274,258,595
JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of EGFR protein] CTD PMID:17934341 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
G Egln1 egl-9 family hypoxia-inducible factor 1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of EGLN1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of EGLN1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of EGLN1 mRNA] CTD PMID:18072750 NCBI chr19:57,660,194...57,701,158
Ensembl chr19:57,662,278...57,699,113
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha increases phosphorylation ISO alpha-naphthoflavone results in increased phosphorylation of EIF2S1 protein CTD PMID:30508555 NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
JBrowse link
G Eno1 enolase 1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ENO1 mRNA] CTD PMID:23152189 NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA] CTD PMID:19028555 NCBI chr 7:94,479,931...94,563,086
Ensembl chr 7:94,480,396...94,563,001
JBrowse link
G Ervfrd-1 endogenous retrovirus group FRD member 1, envelope multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of ERVFRD-1 mRNA] CTD PMID:24361490 NCBI chr12:25,161,130...25,168,182
Ensembl chr12:25,161,130...25,168,182
JBrowse link
G Esr1 estrogen receptor 1 affects binding
multiple interactions
ISO
EXP
[alpha-naphthoflavone binds to AHR protein] which binds to ESR1 protein
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Estradiol binds to ESR1 protein]]; alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Estradiol binds to ESR1 protein]]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Estradiol binds to ESR1 protein]]
[alpha-naphthoflavone co-treated with beta-Naphthoflavone] results in decreased expression of ESR1 mRNA; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ESR1 mRNA]
CTD PMID:10620335, PMID:15253042, PMID:22975028, PMID:29094188 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Esr2 estrogen receptor 2 multiple interactions EXP [alpha-naphthoflavone co-treated with beta-Naphthoflavone] results in decreased expression of ESR2 mRNA CTD PMID:22975028 NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
JBrowse link
G Esrra estrogen related receptor, alpha affects binding ISO [alpha-naphthoflavone binds to AHR protein] which binds to ESRRA protein CTD PMID:10620335 NCBI chr 1:222,168,729...222,178,842
Ensembl chr 1:222,168,730...222,178,725
JBrowse link
G Fas Fas cell surface death receptor multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FAS mRNA] CTD PMID:16940415 NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
JBrowse link
G Faslg Fas ligand multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FASL mRNA] CTD PMID:16940415 NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]] CTD PMID:20876236 NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
JBrowse link
G Flg filaggrin multiple interactions ISO [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FLG mRNA] CTD PMID:21835898 NCBI chr 2:193,565,401...193,574,297 JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of FOS mRNA]] CTD PMID:10478842 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Foxn3 forkhead box N3 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of FOXN3 mRNA] CTD PMID:29094188 NCBI chr 6:123,183,720...123,577,719
Ensembl chr 6:123,187,726...123,577,695
JBrowse link
G Foxo3 forkhead box O3 multiple interactions ISO
EXP
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of FOXO3 protein]
[Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of FOXO3 mRNA
CTD PMID:22266097, PMID:29094188 NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
JBrowse link
G Foxp3 forkhead box P3 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [tetrandrine results in increased expression of FOXP3 mRNA] CTD PMID:26640276 NCBI chr  X:15,753,175...15,768,648
Ensembl chr  X:15,753,175...15,768,522
JBrowse link
G Fshr follicle stimulating hormone receptor multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FSHR protein] CTD PMID:20823264 NCBI chr 6:12,796,383...12,997,817
Ensembl chr 6:12,796,383...12,997,817
JBrowse link
G Gdf9 growth differentiation factor 9 increases expression
multiple interactions
EXP alpha-naphthoflavone results in increased expression of GDF9 mRNA
[Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of GDF9 mRNA
CTD PMID:29094188 NCBI chr10:38,782,519...38,793,238
Ensembl chr10:38,788,992...38,792,940
JBrowse link
G Gpi glucose-6-phosphate isomerase multiple interactions
increases expression
ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GPI mRNA]
alpha-naphthoflavone results in increased expression of GPI mRNA
CTD PMID:23152189 NCBI chr 1:90,063,411...90,091,287
Ensembl chr 1:90,063,411...90,091,287
JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GSR mRNA] CTD PMID:23152189 NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
JBrowse link
G Gstp1 glutathione S-transferase pi 1 decreases expression ISO alpha-naphthoflavone results in decreased expression of GSTP1 mRNA CTD PMID:18762178 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of HES1 mRNA] CTD PMID:29094188 NCBI chr11:74,312,837...74,315,249
Ensembl chr11:74,312,806...74,315,248
JBrowse link
G Hk1 hexokinase 1 multiple interactions
increases expression
ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of HK1 mRNA]
alpha-naphthoflavone results in increased expression of HK1 mRNA
CTD PMID:23152189 NCBI chr20:31,911,460...31,979,780
Ensembl chr20:31,912,262...31,956,649
JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR protein] CTD PMID:19931295 NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of HSPA8 mRNA] CTD PMID:29094188 NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of ICAM1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of ICAM1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of ICAM1 mRNA] CTD PMID:26519956, PMID:29094188 NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
JBrowse link
G Igf2 insulin-like growth factor 2 decreases acetylation
multiple interactions
EXP alpha-naphthoflavone results in decreased acetylation of IGF2 promoter
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of IGF2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of IGF2 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of IGF2 promoter]
CTD PMID:29094188 NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 multiple interactions
increases expression
EXP AHR gene mutant form inhibits the reaction [alpha-naphthoflavone results in increased expression of IGFBP4 protein] CTD PMID:23639626 NCBI chr10:86,950,555...86,962,563
Ensembl chr10:86,950,557...86,962,578
JBrowse link
G Il10 interleukin 10 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene co-treated with Lipopolysaccharides] affects the expression of IL10 mRNA]; alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene co-treated with Lipopolysaccharides] affects the expression of IL10 protein]
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IL10 protein]; alpha-naphthoflavone inhibits the reaction [tetrandrine results in increased expression of IL10 mRNA]
CTD PMID:11737050, PMID:17681673, PMID:26640276 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases expression
decreases expression
ISO alpha-naphthoflavone analog inhibits the reaction [IL1B protein results in increased expression of SAA1 mRNA]; alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B protein]
alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of IL1B mRNA]
alpha-naphthoflavone results in increased expression of IL1B mRNA
alpha-naphthoflavone results in decreased expression of IL1B mRNA
CTD PMID:14993811, PMID:15019843, PMID:18617548, PMID:21127131, PMID:22262711, PMID:27393915 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
JBrowse link
G Il1rn interleukin 1 receptor antagonist multiple interactions
increases expression
ISO alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1RN mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1RN mRNA]
alpha-naphthoflavone results in increased expression of IL1RN mRNA
CTD PMID:22262711 NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
ISO
EXP
alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of IL6 mRNA]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA]
alpha-naphthoflavone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of IL6 mRNA]
alpha-naphthoflavone results in increased expression of IL6 mRNA
CTD PMID:21162728, PMID:26519956 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Itgb8 integrin subunit beta 8 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ITGB8 mRNA] CTD PMID:29094188 NCBI chr 6:147,089,280...147,172,846
Ensembl chr 6:147,094,097...147,172,813
JBrowse link
G Jag1 jagged canonical Notch ligand 1 decreases methylation
multiple interactions
EXP alpha-naphthoflavone results in decreased methylation of JAG1 promoter
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of JAG1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of JAG1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of JAG1 promoter]
CTD PMID:29094188 NCBI chr 3:130,079,361...130,114,781
Ensembl chr 3:130,079,361...130,114,770
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression
ISO
EXP
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of JUN protein]
alpha-naphthoflavone results in increased expression of JUN mRNA
CTD PMID:15019843, PMID:15897893 NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
JBrowse link
G Krt14 keratin 14 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Plant Extracts results in decreased expression of KRT14 mRNA] CTD PMID:25051199 NCBI chr10:88,118,029...88,122,233
Ensembl chr10:88,055,823...88,122,233
JBrowse link
G Ldha lactate dehydrogenase A multiple interactions
increases expression
ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of LDHA mRNA]
alpha-naphthoflavone results in increased expression of LDHA mRNA
CTD PMID:23152189 NCBI chr 1:102,900,288...102,909,713
Ensembl chr 1:102,900,286...102,909,707
JBrowse link
G Lhcgr luteinizing hormone/choriogonadotropin receptor multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LHCGR protein] CTD PMID:20823264 NCBI chr 6:12,493,182...12,554,482
Ensembl chr 6:12,493,943...12,554,439
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
ISO [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK1 protein]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of MAPK1 protein]
alpha-naphthoflavone results in increased phosphorylation of MAPK1 protein
SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased phosphorylation of MAPK1 protein]
CTD PMID:19578757, PMID:20876236, PMID:21205633, PMID:26358519, PMID:30508555 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
ISO [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK3 protein]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK3 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of MAPK3 protein]
SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased phosphorylation of MAPK3 protein]
CTD PMID:19578757, PMID:20876236, PMID:21205633, PMID:26358519, PMID:30508555 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Mdm2 MDM2 proto-oncogene multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA] CTD PMID:19578757 NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
JBrowse link
G Mmp1 matrix metallopeptidase 1 multiple interactions EXP
ISO
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP1 mRNA]
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tretinoin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP1 mRNA]]
CTD PMID:15075337, PMID:19022365 NCBI chr 8:5,703,206...5,723,593
Ensembl chr 8:5,703,206...5,723,591
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP2 mRNA] CTD PMID:19022365 NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP3 mRNA] CTD PMID:19022365 NCBI chr 8:5,676,608...5,698,579
Ensembl chr 8:5,676,665...5,698,579
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP
ISO
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA]
alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein]
CTD PMID:19022365, PMID:23462309 NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
JBrowse link
G Mt1 metallothionein 1 increases expression ISO alpha-naphthoflavone results in increased expression of MT1 mRNA CTD PMID:14998373 NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of MTOR protein] CTD PMID:22266097 NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of MYC protein] CTD PMID:22100782 NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
JBrowse link
G Myog myogenin multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of MYOG protein] CTD PMID:24431215 NCBI chr13:51,126,459...51,129,048
Ensembl chr13:51,126,459...51,129,048
JBrowse link
G Ncf1 neutrophil cytosolic factor 1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of NCF1 mRNA] CTD PMID:19559082 NCBI chr12:25,497,104...25,506,300
Ensembl chr12:25,497,104...25,506,300
JBrowse link
G Ndufs1 NADH:ubiquinone oxidoreductase core subunit S1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NDUFS1 mRNA] CTD PMID:23152189 NCBI chr 9:69,919,863...69,953,182
Ensembl chr 9:69,919,867...69,953,182
JBrowse link
G Ndufs3 NADH:ubiquinone oxidoreductase core subunit S3 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NDUFS3 mRNA] CTD PMID:23152189 NCBI chr 3:79,721,686...79,728,863
Ensembl chr 3:79,721,694...79,728,879
JBrowse link
G Nfatc1 nuclear factor of activated T-cells 1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein] CTD PMID:19028555 NCBI chr18:77,203,517...77,322,690
Ensembl chr18:77,203,525...77,322,690
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein] CTD PMID:26086121 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
JBrowse link
G Notch2 notch receptor 2 decreases acetylation
increases methylation
multiple interactions
EXP alpha-naphthoflavone results in decreased acetylation of NOTCH2 promoter
alpha-naphthoflavone results in increased methylation of NOTCH2 promoter
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of NOTCH2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of NOTCH2 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of NOTCH2 promoter]
CTD PMID:29094188 NCBI chr 2:200,187,184...200,320,403
Ensembl chr 2:200,187,179...200,320,215
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases activity
increases expression
EXP alpha-naphthoflavone results in increased activity of NQO1 protein
alpha-naphthoflavone results in increased expression of NQO1 mRNA
CTD PMID:16906435, PMID:17069994 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases activity EXP alpha-naphthoflavone results in increased activity of NR1I3 protein CTD PMID:27732639 NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 affects binding ISO [alpha-naphthoflavone binds to AHR protein] which binds to NR2F1 protein CTD PMID:10620335 NCBI chr 2:5,569,954...5,579,894
Ensembl chr 2:5,569,935...5,579,894
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO alpha-naphthoflavone results in increased cleavage of PARP1 protein CTD PMID:30508555 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
JBrowse link
G Pfkm phosphofructokinase, muscle multiple interactions
increases expression
ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PFKM mRNA]
alpha-naphthoflavone results in increased expression of PFKM mRNA
CTD PMID:23152189 NCBI chr 7:139,702,066...139,722,132
Ensembl chr 7:139,685,573...139,722,132
JBrowse link
G Pgk1 phosphoglycerate kinase 1 multiple interactions
increases expression
ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGK1 mRNA]
alpha-naphthoflavone results in increased expression of PGK1 mRNA
CTD PMID:23152189 NCBI chr  X:77,263,399...77,279,373
Ensembl chr  X:77,263,359...77,279,367
JBrowse link
G Pgm1 phosphoglucomutase 1 increases expression
multiple interactions
ISO alpha-naphthoflavone results in increased expression of PGM1 mRNA
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGM1 mRNA]
CTD PMID:23152189 NCBI chr 5:118,743,632...118,803,055
Ensembl chr 5:118,743,632...118,803,055
JBrowse link
G Pgr progesterone receptor increases expression ISO alpha-naphthoflavone results in increased expression of PGR protein CTD PMID:22266097 NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
JBrowse link
G Pkm pyruvate kinase M1/2 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PKM mRNA] CTD PMID:23152189 NCBI chr 8:64,480,963...64,502,957
Ensembl chr 8:64,481,172...64,502,722
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO alpha-naphthoflavone inhibits the reaction [beta-Naphthoflavone results in increased expression of PPARA protein] CTD PMID:21849270 NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
JBrowse link
G Prdm1 PR/SET domain 1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA] CTD PMID:20562217 NCBI chr20:49,464,921...49,556,623
Ensembl chr20:49,464,919...49,556,518
JBrowse link
G Prkcb protein kinase C, beta multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of PRKCB protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of PRKCB protein] CTD PMID:16797713, PMID:17222441 NCBI chr 1:192,233,569...192,575,339
Ensembl chr 1:192,233,910...192,574,831
JBrowse link
G Prl prolactin multiple interactions EXP alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of PRL mRNA] CTD PMID:22975028 NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression
multiple interactions
increases expression
ISO alpha-naphthoflavone results in decreased expression of PTGS2 mRNA
alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]
alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased expression of PTGS2 protein]; alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions results in increased expression of PTGS2 mRNA]
alpha-naphthoflavone results in increased expression of PTGS2 mRNA
CTD PMID:21162728, PMID:22262711, PMID:26358519, PMID:27393915 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
JBrowse link
G Ptk2 protein tyrosine kinase 2 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased phosphorylation of PTK2 protein] CTD PMID:16359657 NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
JBrowse link
G Rack1 receptor for activated C kinase 1 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RACK1 protein] CTD PMID:16797713, PMID:17222441 NCBI chr10:34,149,717...34,155,198
Ensembl chr10:34,149,717...34,155,198
Ensembl chr12:34,149,717...34,155,198
JBrowse link
G Rb1 RB transcriptional corepressor 1 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of RB1 protein] CTD PMID:15157999 NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO alpha-naphthoflavone inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of RELA protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of RELA protein] CTD PMID:24431215 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
JBrowse link
G Serpinb2 serpin family B member 2 multiple interactions
decreases expression
increases expression
ISO alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SERPINB2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SERPINB2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tretinoin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of SERPINB2 mRNA]]
alpha-naphthoflavone results in decreased expression of SERPINB2 mRNA
alpha-naphthoflavone results in increased expression of SERPINB2 mRNA
CTD PMID:15075337, PMID:22262711 NCBI chr13:27,449,907...27,463,015
Ensembl chr13:27,449,934...27,463,010
JBrowse link
G Slc2a1 solute carrier family 2 member 1 multiple interactions
increases expression
ISO alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA]
alpha-naphthoflavone results in increased expression of SLC2A1 mRNA
CTD PMID:23152189 NCBI chr 5:138,154,677...138,182,897
Ensembl chr 5:138,154,673...138,182,897
JBrowse link
G Slc5a5 solute carrier family 5 member 5 multiple interactions EXP alpha-naphthoflavone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in decreased expression of SLC5A5 protein] CTD PMID:26519956 NCBI chr16:20,297,414...20,307,401
Ensembl chr16:20,297,414...20,307,400
JBrowse link
G Smad3 SMAD family member 3 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of SMAD3 protein] CTD PMID:27519288 NCBI chr 8:68,569,530...68,678,349
Ensembl chr 8:68,569,530...68,678,349
JBrowse link
G Sp1 Sp1 transcription factor multiple interactions EXP alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to SP1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of SP1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of SP1 mRNA] CTD PMID:29094188 NCBI chr 7:144,014,173...144,044,635
Ensembl chr 7:144,014,173...144,044,629
JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase multiple interactions
increases phosphorylation
ISO SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of CYP1A1 mRNA]; SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]
alpha-naphthoflavone results in increased phosphorylation of SRC protein
CTD PMID:30508555 NCBI chr 3:153,547,807...153,595,643
Ensembl chr 3:153,580,861...153,595,642
JBrowse link
G Stat5b signal transducer and activator of transcription 5B multiple interactions ISO [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of STAT5B protein] CTD PMID:21205633 NCBI chr10:88,686,207...88,712,313
Ensembl chr10:88,686,207...88,754,829
JBrowse link
G Tcf7 transcription factor 7 increases expression ISO alpha-naphthoflavone results in increased expression of TCF7 mRNA CTD PMID:18762178 NCBI chr10:37,616,033...37,646,027
Ensembl chr10:37,617,279...37,645,802
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP
ISO
alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of TGFB1 mRNA]
alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased expression of TGFB1 mRNA]
CTD PMID:22975028, PMID:27519288 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
JBrowse link
G Tiparp TCDD-inducible poly(ADP-ribose) polymerase decreases expression ISO alpha-naphthoflavone results in decreased expression of TIPARP mRNA CTD PMID:18762178 NCBI chr 2:157,316,293...157,342,979
Ensembl chr 2:157,316,266...157,341,469
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of TNF mRNA]
alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of TNF mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TNF mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased secretion of TNF protein]
CTD PMID:17934341, PMID:20801209, PMID:23099484 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Tnfsf11 TNF superfamily member 11 multiple interactions ISO alpha-naphthoflavone inhibits the reaction [norisoboldine inhibits the reaction [TNFSF11 protein results in increased expression of VEGFA mRNA]] CTD PMID:26221077 NCBI chr15:60,482,527...60,512,704
Ensembl chr15:60,482,527...60,512,704
JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression
EXP
ISO
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [leptomycin B results in increased expression of TP53 protein]]
alpha-naphthoflavone results in increased expression of TP53 protein
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene affects the localization of TRP53 protein]
CTD PMID:9006915, PMID:15459018, PMID:29274324 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
JBrowse link
G Tpi1 triosephosphate isomerase 1 increases expression
multiple interactions
ISO alpha-naphthoflavone results in increased expression of TPI1 mRNA
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TPI1 mRNA]
CTD PMID:23152189 NCBI chr 4:157,328,375...157,331,905
Ensembl chr 4:157,328,379...157,331,905
JBrowse link
G Vdr vitamin D receptor multiple interactions ISO alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]] CTD PMID:19244278 NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO
EXP
alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of VEGFA protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of VEGFA protein]
alpha-naphthoflavone inhibits the reaction [norisoboldine results in decreased expression of VEGFA mRNA]
alpha-naphthoflavone inhibits the reaction [norisoboldine inhibits the reaction [TNFSF11 protein results in increased expression of VEGFA mRNA]]
CTD PMID:19182260, PMID:26221077, PMID:26358519 NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
JBrowse link
G Wapl WAPL cohesin release factor multiple interactions ISO alpha-naphthoflavone promotes the reaction [3-methylcholanthrylene results in increased expression of WAPL mRNA] CTD PMID:15797623 NCBI chr16:11,029,325...11,108,867
Ensembl chr16:11,032,531...11,106,589
JBrowse link
beta-naphthoflavone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A1bg alpha-1-B glycoprotein multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of A1BG mRNA CTD PMID:18164116 NCBI chr 7:102,294,805...102,298,522
Ensembl chr 7:102,294,797...102,298,522
JBrowse link
G A2m alpha-2-macroglobulin decreases expression EXP beta-Naphthoflavone results in decreased expression of A2M mRNA CTD PMID:12883083 NCBI chr 4:154,309,426...154,359,138
Ensembl chr 4:154,309,426...154,359,137
JBrowse link
G A3galt2 alpha 1,3-galactosyltransferase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of A3GALT2 mRNA CTD PMID:18164116 NCBI chr 5:146,933,592...146,945,882
Ensembl chr 5:146,933,592...146,945,880
JBrowse link
G Aadac arylacetamide deacetylase decreases expression ISO beta-Naphthoflavone results in decreased expression of AADAC mRNA CTD PMID:22429928 NCBI chr 2:150,146,234...150,157,480
Ensembl chr 2:150,146,234...150,157,480
JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 increases expression EXP beta-Naphthoflavone results in increased expression of ABCC1 mRNA CTD PMID:11752103 NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression
multiple interactions
decreases expression
EXP
ISO
beta-Naphthoflavone results in increased expression of ABCC2 mRNA
[beta-Naphthoflavone binds to AHR protein] which results in increased expression of ABCC2 mRNA
beta-Naphthoflavone results in decreased expression of ABCC2 mRNA
CTD PMID:11752103, PMID:15833929, PMID:16426233, PMID:19737606, PMID:20607812, PMID:22258563 NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions
increases expression
ISO
EXP
[beta-Naphthoflavone binds to AHR protein] which results in increased expression of ABCC3 mRNA
beta-Naphthoflavone results in increased expression of ABCC3 mRNA
CTD PMID:15833929, PMID:19118567, PMID:23994337 NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of ABCC4 mRNA CTD PMID:19737545 NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 increases expression
multiple interactions
ISO beta-Naphthoflavone results in increased expression of ABCC5 mRNA
[beta-Naphthoflavone binds to AHR protein] which results in increased expression of ABCC5 mRNA
CTD PMID:15833929 NCBI chr11:84,395,982...84,490,215
Ensembl chr11:84,396,033...84,490,211
JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 increases expression
multiple interactions
ISO beta-Naphthoflavone results in increased expression of ABCC6 mRNA
[beta-Naphthoflavone binds to AHR protein] which results in increased expression of ABCC6 mRNA
CTD PMID:15833929 NCBI chr 1:101,954,786...102,013,252
Ensembl chr 1:101,959,540...102,013,243
JBrowse link
G Abcc9 ATP binding cassette subfamily C member 9 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ABCC9 mRNA CTD PMID:18164116 NCBI chr 4:176,806,098...176,928,540
Ensembl chr 4:176,805,431...176,922,424
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ABCG1 mRNA CTD PMID:18164116 NCBI chr20:9,743,269...9,842,735
Ensembl chr20:9,743,269...9,840,489
JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 increases expression ISO beta-Naphthoflavone results in increased expression of ABCG2 mRNA CTD PMID:19737606 NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
JBrowse link
G Acacb acetyl-CoA carboxylase beta multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACACB mRNA CTD PMID:18164116 NCBI chr12:48,127,149...48,238,969
Ensembl chr12:48,127,149...48,238,887
JBrowse link
G Acap2 ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ACAP2 mRNA CTD PMID:18164116 NCBI chr11:73,078,966...73,193,496
Ensembl chr11:73,078,982...73,191,132
JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 multiple interactions
decreases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACAT2 mRNA
beta-Naphthoflavone results in decreased expression of ACAT2 mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of ACAT2 mRNA]
CTD PMID:18164116, PMID:22234961, PMID:31225620 NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
JBrowse link
G Acbd3 acyl-CoA binding domain containing 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ACBD3 mRNA CTD PMID:18164116 NCBI chr13:99,004,942...99,035,520
Ensembl chr13:99,004,942...99,035,519
JBrowse link
G Ace angiotensin I converting enzyme multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ACE mRNA CTD PMID:18164116 NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
JBrowse link
G Acot1 acyl-CoA thioesterase 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ACOT1 mRNA CTD PMID:18164116 NCBI chr 6:107,485,088...107,493,082
Ensembl chr 6:107,485,249...107,493,798
JBrowse link
G Acot7 acyl-CoA thioesterase 7 increases expression ISO beta-Naphthoflavone results in increased expression of ACOT7 mRNA CTD PMID:23994337 NCBI chr 5:169,357,582...169,450,215
Ensembl chr 5:169,357,517...169,450,219
JBrowse link
G Acsl3 acyl-CoA synthetase long-chain family member 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACSL3 mRNA CTD PMID:18164116 NCBI chr 9:84,569,601...84,593,565
Ensembl chr 9:84,569,597...84,593,565
JBrowse link
G Acvrl1 activin A receptor like type 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACVRL1 mRNA CTD PMID:18164116 NCBI chr 7:142,769,942...142,787,336
Ensembl chr 7:142,776,252...142,787,335
JBrowse link
G Acy1 aminoacylase 1 increases expression ISO beta-Naphthoflavone results in increased expression of ACY1 mRNA CTD PMID:23994337 NCBI chr 8:115,134,792...115,140,171
Ensembl chr 8:115,134,765...115,140,080
JBrowse link
G Adam2 ADAM metallopeptidase domain 2 increases expression ISO beta-Naphthoflavone results in increased expression of ADAM2 mRNA CTD PMID:23994337 NCBI chr15:42,708,536...42,751,281
Ensembl chr15:42,708,387...42,751,330
JBrowse link
G Adcy3 adenylate cyclase 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ADCY3 mRNA CTD PMID:18164116 NCBI chr 6:28,570,941...28,648,848
Ensembl chr 6:28,571,351...28,650,148
JBrowse link
G Adcy8 adenylate cyclase 8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ADCY8 mRNA CTD PMID:18164116 NCBI chr 7:105,353,883...105,593,372
Ensembl chr 7:105,353,913...105,592,804
JBrowse link
G Adgrg1 adhesion G protein-coupled receptor G1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ADGRG1 mRNA CTD PMID:18164116 NCBI chr19:10,423,534...10,460,674
Ensembl chr19:10,423,501...10,460,674
JBrowse link
G Adgrg2 adhesion G protein-coupled receptor G2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ADGRG2 mRNA CTD PMID:18164116 NCBI chr  X:36,930,186...37,054,968
Ensembl chr  X:36,930,186...37,003,642
JBrowse link
G Adgrl2 adhesion G protein-coupled receptor L2 multiple interactions
decreases expression
ISO AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of ADGRL2 mRNA] CTD PMID:22234961 NCBI chr 2:258,792,838...258,997,145
Ensembl chr 2:258,792,839...258,997,145
JBrowse link
G Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of ADH7 mRNA CTD PMID:19737545 NCBI chr 2:243,500,540...243,516,865
Ensembl chr 2:243,502,073...243,516,532
JBrowse link
G Adm adrenomedullin increases expression ISO beta-Naphthoflavone results in increased expression of ADM mRNA CTD PMID:19737606 NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
JBrowse link
G Adrb3 adrenoceptor beta 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ADRB3 mRNA CTD PMID:18164116 NCBI chr16:69,003,541...69,006,632
Ensembl chr16:69,003,868...69,006,632
JBrowse link
G Adrm1 adhesion regulating molecule 1 increases expression ISO beta-Naphthoflavone results in increased expression of ADRM1 mRNA CTD PMID:19737606 NCBI chr 3:175,548,181...175,552,943
Ensembl chr 3:175,548,174...175,552,947
JBrowse link
G Agxt alanine--glyoxylate and serine--pyruvate aminotransferase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AGXT mRNA CTD PMID:18164116 NCBI chr 9:100,281,339...100,291,292
Ensembl chr 9:100,281,339...100,291,291
JBrowse link
G Ahr aryl hydrocarbon receptor affects binding
increases activity
multiple interactions
affects response to substance
decreases expression
increases expression
affects folding
affects localization
ISO
EXP
[beta-Naphthoflavone binds to AHR protein] which binds to ESR1 protein; [beta-Naphthoflavone binds to AHR protein] which binds to ESRRA protein; [beta-Naphthoflavone binds to AHR protein] which binds to NR2F1 protein; beta-Naphthoflavone binds to AHR protein
beta-Naphthoflavone results in increased activity of AHR protein
15,16-dihydrotanshinone I promotes the reaction [beta-Naphthoflavone results in increased expression of AHR mRNA]; [beta-Naphthoflavone binds to and results in increased activity of AHR protein] results in decreased susceptibility to [1-nitropyrene results in increased expression of TP53 protein]; [beta-Naphthoflavone results in increased activity of AHR protein] which results in decreased chemical synthesis of and results in decreased secretion of Cholesterol; AHR gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]]; AHR mutant form inhibits the reaction [beta-Naphthoflavone results in increased activity of [FASLG protein binds to FASLG protein]]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYP1A1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of FDFT1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of HMGCR mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of LSS mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of SQLE mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone binds to and results in increased activity of AHR protein; beta-Naphthoflavone binds to and results in increased activity of AHR protein polymorphism; beta-Naphthoflavone binds to and results in increased activity of and results in increased localization of AHR protein; beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; beta-Naphthoflavone promotes the reaction [[AHR protein binds to UGT1A1 enhancer] which results in increased expression of UGT1A1 mRNA]; beta-Naphthoflavone promotes the reaction [AHR protein binds to ARNT protein]; beta-Naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]; Carbaryl inhibits the reaction [beta-Naphthoflavone binds to and results in increased activity of AHR protein]; cryptotanshinone promotes the reaction [beta-Naphthoflavone results in increased expression of AHR mRNA]; NR1I2 protein inhibits the reaction [beta-Naphthoflavone results in increased expression of AHR mRNA]; Pregnenolone Carbonitrile promotes the reaction [NR1I2 protein inhibits the reaction [beta-Naphthoflavone results in increased expression of AHR mRNA]]; tanshinone promotes the reaction [beta-Naphthoflavone results in increased expression of AHR mRNA]
AHR gene alternative form affects the susceptibility to beta-Naphthoflavone; AHR protein affects the susceptibility to beta-Naphthoflavone
[beta-Naphthoflavone binds to AHR protein] which results in increased expression of ABCC2 mRNA; [beta-Naphthoflavone binds to AHR protein] which results in increased expression of ABCC3 mRNA; [beta-Naphthoflavone binds to AHR protein] which results in increased expression of ABCC5 mRNA; [beta-Naphthoflavone binds to AHR protein] which results in increased expression of ABCC6 mRNA; [beta-Naphthoflavone binds to and affects the localization of AHR protein] promotes the reaction [[AHR protein binds to CYP1A1 enhancer] which results in increased expression of CYP1A1 mRNA]; [beta-Naphthoflavone binds to and affects the localization of AHR protein] which results in increased expression of CYP1A1 mRNA; [furafylline results in decreased activity of CYP1A2 protein] promotes the reaction [beta-Naphthoflavone results in increased activity of AHR protein]; AHR affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; AHR affects the reaction [beta-Naphthoflavone results in increased expression of PPARA mRNA]; AHR affects the reaction [beta-Naphthoflavone results in increased expression of PPARA protein]; AHR gene alternative form affects the reaction [beta-Naphthoflavone results in decreased expression of CSN2 mRNA]; AHR gene alternative form affects the reaction [beta-Naphthoflavone results in decreased expression of LALBA mRNA]; AHR gene alternative form affects the reaction [beta-Naphthoflavone results in decreased expression of WAP mRNA]; AHR gene alternative form affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; AHR promotes the reaction [beta-Naphthoflavone results in decreased abundance of Lactic Acid]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of ACAT2 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of ADGRL2 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CES2E mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CES3 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of COQ10B mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYB5B mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYP51 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of DHCR7 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of DMGDH mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of FDFT1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of FOS protein]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of GBP6 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of HAGH mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of HMGCR mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of HMGCS1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of HSD17B7 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of IDI1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of IRGM mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of LSS mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of MSMO1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of MVD mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of NAT8F2 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of NSDHL mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of PCSK9 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of PMVK mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of RCAN2 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of RDH11 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of SERPINA7 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of SQLE mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of UGCG mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in increased expression of UBE2L3 mRNA]; AHR protein promotes the reaction [beta-Naphthoflavone results in increased activity of CRYZ protein]; beta-Naphthoflavone binds to and affects the localization of AHR protein; beta-Naphthoflavone binds to and results in increased activity of AHR protein; beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; beta-Naphthoflavone promotes the reaction [AHR protein binds to ARNT protein]; beta-Naphthoflavone promotes the reaction [AHR protein binds to ARNTL protein]; beta-Naphthoflavone promotes the reaction [AHR protein binds to PER1 promoter]; beta-Naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]; kaempferol inhibits the reaction [beta-Naphthoflavone promotes the reaction [AHR protein binds to ARNT protein]]; kaempferol inhibits the reaction [beta-Naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]]
beta-Naphthoflavone results in decreased expression of AHR mRNA
AHR protein promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of AHR mRNA]; beta-Naphthoflavone binds to and results in increased activity of AHR protein; beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
beta-Naphthoflavone affects the folding of AHR protein
beta-Naphthoflavone affects the localization of AHR protein
beta-Naphthoflavone results in decreased expression of AHR mRNA; beta-Naphthoflavone results in decreased expression of AHR protein
CTD PMID:3005314, PMID:9407059, PMID:10620335, PMID:11752103, PMID:11752201, PMID:12409613, PMID:12527811, PMID:12566446, PMID:12948865, PMID:15297030, PMID:15371557, PMID:15833929, PMID:15860653, PMID:15919853, PMID:16399344, PMID:16705413, PMID:16985168, PMID:17012224, PMID:17431010, PMID:17553063, PMID:17627975, PMID:18835618, PMID:19327395, PMID:19901195, PMID:20106950, PMID:20634293, PMID:21127131, PMID:21262253, PMID:21292640, PMID:21849270, PMID:22044530, PMID:22234961, PMID:22491429, PMID:22951985, PMID:22975028, PMID:23377616, PMID:23439660, PMID:24161567, PMID:24486526, PMID:25716673, PMID:26187274, PMID:26204831, PMID:26318284, PMID:26593447, PMID:28428138, PMID:29274324, PMID:29521512, PMID:30203046, PMID:31225620, PMID:32151702 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor multiple interactions
increases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AHRR mRNA
beta-Naphthoflavone results in increased expression of AHRR mRNA
CTD PMID:12520768, PMID:18164116, PMID:25218365 NCBI chr 1:31,603,297...31,698,329
Ensembl chr 1:31,603,297...31,698,329
JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 increases expression ISO beta-Naphthoflavone results in increased expression of AKR1A1 mRNA CTD PMID:9973208 NCBI chr 5:135,482,068...135,498,693
Ensembl chr 5:135,482,068...135,498,822
JBrowse link
G Akr1b8 aldo-keto reductase family 1, member B8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR1B8 mRNA CTD PMID:18164116 NCBI chr 4:61,772,064...61,784,637
Ensembl chr 4:61,771,970...61,828,657
JBrowse link
G Akr1c15 aldo-keto reductase family 1, member C15 increases expression ISO beta-Naphthoflavone results in increased expression of AKR1C8P mRNA CTD PMID:32151702 NCBI chr17:69,835,338...69,862,093
Ensembl chr17:69,835,330...69,862,110
JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases expression
multiple interactions
ISO
EXP
beta-Naphthoflavone results in increased expression of AKR1C3 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AKR1C18 mRNA
CTD PMID:18164116, PMID:19737606, PMID:32151702 NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 decreases expression ISO beta-Naphthoflavone results in decreased expression of AKR1D1 mRNA CTD PMID:19737606 NCBI chr 4:65,110,706...65,143,930
Ensembl chr 4:65,110,746...65,143,941
JBrowse link
G Akr1e2 aldo-keto reductase family 1, member E2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR1E1 mRNA CTD PMID:18164116 NCBI chr17:69,365,437...69,379,944
Ensembl chr17:69,365,453...69,379,947
JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 increases expression EXP beta-Naphthoflavone results in increased expression of AKR7A2 mRNA; beta-Naphthoflavone results in increased expression of AKR7A2 protein CTD PMID:19389873 NCBI chr 5:157,759,448...157,768,473
Ensembl chr 5:157,759,416...157,768,471
JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 multiple interactions
increases expression
EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR7A3 mRNA
beta-Naphthoflavone results in increased expression of AKR7A3 mRNA
CTD PMID:18164116, PMID:22687991 NCBI chr 5:157,801,120...157,813,756
Ensembl chr 5:157,801,163...157,813,756
JBrowse link
G Alas2 5'-aminolevulinate synthase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALAS2 mRNA CTD PMID:18164116 NCBI chr  X:23,167,576...23,187,356
Ensembl chr  X:23,167,696...23,187,341
JBrowse link
G Alb albumin decreases expression ISO beta-Naphthoflavone results in decreased expression of ALB mRNA CTD PMID:23994337 NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALDH1A1 mRNA CTD PMID:21295105 NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 increases expression ISO beta-Naphthoflavone results in increased expression of ALDH1B1 mRNA CTD PMID:17998271 NCBI chr 5:61,382,351...61,387,359
Ensembl chr 5:61,382,351...61,387,358
JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression
multiple interactions
EXP
ISO
beta-Naphthoflavone results in increased expression of ALDH3A1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALDH3A1 mRNA
CTD PMID:1416978, PMID:17998271, PMID:18164116, PMID:23994337, PMID:25218365, PMID:28601433, PMID:32151702 NCBI chr10:47,490,168...47,499,855
Ensembl chr10:47,490,153...47,499,876
JBrowse link
G Aldh3b1 aldehyde dehydrogenase 3 family, member B1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALDH3B1 mRNA CTD PMID:18164116 NCBI chr 1:219,145,457...219,181,536
Ensembl chr 1:219,145,459...219,186,860
JBrowse link
G Aldh8a1 aldehyde dehydrogenase 8 family, member A1 decreases expression ISO beta-Naphthoflavone results in decreased expression of ALDH8A1 mRNA CTD PMID:19737606 NCBI chr 1:16,910,043...16,929,465
Ensembl chr 1:16,910,069...16,930,481
JBrowse link
G Alox5 arachidonate 5-lipoxygenase increases expression ISO beta-Naphthoflavone results in increased expression of ALOX5 mRNA CTD PMID:19737606 NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALPL mRNA CTD PMID:18164116 NCBI chr 5:156,086,496...156,141,513
Ensembl chr 5:156,086,497...156,141,537
JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AMPD3 mRNA CTD PMID:18164116 NCBI chr 1:175,585,301...175,630,479
Ensembl chr 1:175,586,097...175,630,467
JBrowse link
G Ankrd1 ankyrin repeat domain 1 multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of ANKRD1 mRNA CTD PMID:19737545 NCBI chr 1:254,726,985...254,745,673
Ensembl chr 1:254,726,969...254,735,548
JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANP32A mRNA CTD PMID:18164116 NCBI chr 8:67,295,578...67,333,075
Ensembl chr 8:67,295,727...67,333,247
JBrowse link
G Anxa1 annexin A1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA1 mRNA CTD PMID:18164116 NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
JBrowse link
G Anxa4 annexin A4 decreases expression ISO beta-Naphthoflavone results in decreased expression of ANXA4 mRNA CTD PMID:23994337 NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
JBrowse link
G Anxa5 annexin A5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA5 mRNA CTD PMID:18164116 NCBI chr 2:123,162,477...123,194,730
Ensembl chr 2:123,162,461...123,193,130
JBrowse link
G Anxa8 annexin A8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA8 mRNA CTD PMID:18164116 NCBI chr16:10,417,174...10,432,388
Ensembl chr16:10,417,185...10,432,393
JBrowse link
G Ap1s1 adaptor related protein complex 1 subunit sigma 1 increases expression ISO beta-Naphthoflavone results in increased expression of AP1S1 mRNA CTD PMID:23994337 NCBI chr12:22,665,128...22,676,079
Ensembl chr12:22,665,112...22,676,075
JBrowse link
G Apcs amyloid P component, serum multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of APCS mRNA CTD PMID:18164116 NCBI chr13:91,426,621...91,427,417
Ensembl chr13:91,426,479...91,427,575
JBrowse link
G Apln apelin multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of APLN mRNA CTD PMID:18164116 NCBI chr  X:134,856,719...134,866,210
Ensembl chr  X:134,856,726...134,866,210
JBrowse link
G Apoa4 apolipoprotein A4 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of APOA4 mRNA CTD PMID:18164116 NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
JBrowse link
G Apoa5 apolipoprotein A5 decreases expression ISO beta-Naphthoflavone results in decreased expression of APOA5 mRNA CTD PMID:19737606 NCBI chr 8:50,559,079...50,561,720
Ensembl chr 8:50,559,126...50,561,736
JBrowse link
G Apom apolipoprotein M multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of APOM mRNA CTD PMID:18164116 NCBI chr20:5,120,473...5,123,073
Ensembl chr20:5,120,474...5,123,073
JBrowse link
G Aprt adenine phosphoribosyl transferase increases expression ISO beta-Naphthoflavone results in increased expression of APRT mRNA CTD PMID:23994337 NCBI chr19:55,387,288...55,389,256
Ensembl chr19:55,387,288...55,389,256
JBrowse link
G Aptx aprataxin increases expression ISO beta-Naphthoflavone results in increased expression of APTX mRNA CTD PMID:23994337 NCBI chr 5:56,987,714...57,009,481
Ensembl chr 5:56,987,909...57,008,859
JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARHGEF2 mRNA CTD PMID:18164116 NCBI chr 2:187,964,100...188,022,847
Ensembl chr 2:187,977,008...188,021,377
JBrowse link
G Arl3 ADP ribosylation factor like GTPase 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ARL3 mRNA CTD PMID:18164116 NCBI chr 1:266,287,015...266,333,099
Ensembl chr 1:266,287,017...266,333,105
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO ARNT affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; ARNT promotes the reaction [beta-Naphthoflavone results in decreased abundance of Lactic Acid]; beta-Naphthoflavone promotes the reaction [AHR protein binds to ARNT protein]; beta-Naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]; kaempferol inhibits the reaction [beta-Naphthoflavone promotes the reaction [AHR protein binds to ARNT protein]]; kaempferol inhibits the reaction [beta-Naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]]
AHR gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]]; beta-Naphthoflavone promotes the reaction [AHR protein binds to ARNT protein]; beta-Naphthoflavone results in increased activity of [AHR protein binds to ARNT protein]
CTD PMID:17012224, PMID:19901195, PMID:21127131, PMID:21849270, PMID:24486526 NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
JBrowse link
G Arnt2 aryl hydrocarbon receptor nuclear translocator 2 increases expression ISO beta-Naphthoflavone results in increased expression of ARNT2 mRNA CTD PMID:32151702 NCBI chr 1:146,399,217...146,556,437
Ensembl chr 1:146,399,217...146,556,171
JBrowse link
G Arntl aryl hydrocarbon receptor nuclear translocator-like multiple interactions
increases expression
ISO
EXP
ARNTL affects the reaction [beta-Naphthoflavone results in increased expression of PPARA mRNA]; beta-Naphthoflavone inhibits the reaction [CLOCK protein binds to ARNTL protein]; beta-Naphthoflavone promotes the reaction [AHR protein binds to ARNTL protein]
beta-Naphthoflavone results in increased expression of ARNTL mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ARNTL mRNA
CTD PMID:18164116, PMID:20106950, PMID:21849270, PMID:32151702 NCBI chr 1:178,039,002...178,137,469
Ensembl chr 1:178,039,063...178,137,465
JBrowse link
G Arrdc2 arrestin domain containing 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARRDC2 mRNA CTD PMID:18164116 NCBI chr16:20,352,480...20,356,612
Ensembl chr16:20,352,480...20,356,612
JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression ISO beta-Naphthoflavone results in increased expression of ASNS mRNA CTD PMID:17175557 NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
JBrowse link
G Atp1b3 ATPase Na+/K+ transporting subunit beta 3 increases expression ISO beta-Naphthoflavone results in increased expression of ATP1B3 mRNA CTD PMID:23994337 NCBI chr 8:104,190,032...104,221,342
Ensembl chr 8:104,190,032...104,221,342
JBrowse link
G Atp2b2 ATPase plasma membrane Ca2+ transporting 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ATP2B2 mRNA CTD PMID:18164116 NCBI chr 4:145,704,779...145,948,997
Ensembl chr 4:145,703,046...146,016,325
JBrowse link
G Atp5f1b ATP synthase F1 subunit beta multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ATP5F1B protein; [Piperonyl Butoxide co-treated with beta-Naphthoflavone] results in decreased expression of ATP5F1B protein CTD PMID:28903497 NCBI chr 7:2,504,708...2,511,748
Ensembl chr 7:2,504,695...2,511,749
JBrowse link
G Atxn10 ataxin 10 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ATXN10 mRNA CTD PMID:18164116 NCBI chr 7:126,228,416...126,351,728
Ensembl chr 7:126,228,295...126,351,634
JBrowse link
G Aup1 AUP1, lipid droplet regulating VLDL assembly factor increases expression ISO beta-Naphthoflavone results in increased expression of AUP1 mRNA CTD PMID:23994337 NCBI chr 4:113,887,030...113,890,103
Ensembl chr 4:113,887,115...113,890,101
JBrowse link
G Avil advillin multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AVIL mRNA CTD PMID:18164116 NCBI chr 7:70,292,565...70,310,588
Ensembl chr 7:70,292,565...70,310,588
JBrowse link
G Awat1 acyl-CoA wax alcohol acyltransferase 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of AWAT1 mRNA CTD PMID:28973660 NCBI chr  X:70,408,124...70,414,369
Ensembl chr  X:70,408,064...70,414,368
JBrowse link
G B3galnt1 beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of B3GALNT1 mRNA CTD PMID:18164116 NCBI chr 2:166,226,736...166,255,978
Ensembl chr 2:166,226,754...166,255,302
JBrowse link
G Banf1 BAF nuclear assembly factor 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of BANF1 mRNA CTD PMID:23994337 NCBI chr 1:220,744,195...220,746,224
Ensembl chr 1:220,744,195...220,746,224
JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BASP1 mRNA CTD PMID:18164116 NCBI chr 2:77,586,424...77,632,626
Ensembl chr 2:77,586,424...77,632,628
JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression
multiple interactions
EXP beta-Naphthoflavone results in increased expression of BCL2 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BCL2 mRNA
CTD PMID:21295105, PMID:22687991 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
JBrowse link
G Bex3 brain expressed X-linked 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BEX3 mRNA CTD PMID:18164116 NCBI chr  X:106,823,442...106,825,016
Ensembl chr  X:106,823,491...106,825,014
JBrowse link
G Bex4 brain expressed, X-linked 4 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BEX4 mRNA CTD PMID:18164116
G Bhlhe41 basic helix-loop-helix family, member e41 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BHLHE41 mRNA CTD PMID:18164116 NCBI chr 4:180,230,742...180,235,138
Ensembl chr 4:180,232,382...180,234,804
JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of BHMT mRNA CTD PMID:19737545 NCBI chr 2:23,236,573...23,256,158
Ensembl chr 2:23,236,575...23,256,158
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 increases expression ISO beta-Naphthoflavone results in increased expression of BIRC3 mRNA CTD PMID:32151702 NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BIRC5 mRNA CTD PMID:18164116 NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
JBrowse link
G Blnk B-cell linker multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BLNK mRNA CTD PMID:18164116 NCBI chr 1:260,187,023...260,254,490
Ensembl chr 1:260,186,967...260,254,600
JBrowse link
G Blvrb biliverdin reductase B multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of BLVRB mRNA CTD PMID:19737545 NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075
JBrowse link
G Bok BCL2 family apoptosis regulator BOK multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BOK mRNA CTD PMID:18164116 NCBI chr 9:100,829,593...100,840,498
Ensembl chr 9:100,829,552...100,840,504
JBrowse link
G Brinp1 BMP/retinoic acid inducible neural specific 1 increases expression ISO beta-Naphthoflavone results in increased expression of BRINP1 mRNA CTD PMID:19737606 NCBI chr 5:84,919,416...85,123,828
Ensembl chr 5:84,919,367...85,123,829
JBrowse link
G Bspry B-box and SPRY domain containing multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BSPRY mRNA CTD PMID:18164116 NCBI chr 5:78,334,284...78,356,462
Ensembl chr 5:78,334,284...78,356,460
JBrowse link
G Btg3 BTG anti-proliferation factor 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BTG3 mRNA CTD PMID:18164116 NCBI chr11:16,873,642...16,889,100
Ensembl chr11:16,873,646...16,889,201
JBrowse link
G Ca11 carbonic anhydrase 11 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAR11 mRNA CTD PMID:18164116 NCBI chr 1:101,682,009...101,687,358
Ensembl chr 1:101,682,172...101,687,293
JBrowse link
G Ca3 carbonic anhydrase 3 multiple interactions
decreases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CA3 mRNA
beta-Naphthoflavone results in decreased expression of CAR3 mRNA
CTD PMID:18164116, PMID:23994337 NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
JBrowse link
G Cab39l calcium binding protein 39-like multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CAB39L mRNA CTD PMID:18164116 NCBI chr15:39,745,124...39,849,022
Ensembl chr15:39,759,257...39,870,208
JBrowse link
G Cacna2d1 calcium voltage-gated channel auxiliary subunit alpha2delta 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CACNA2D1 mRNA CTD PMID:18164116 NCBI chr 4:15,706,974...16,130,848
Ensembl chr 4:15,710,417...16,130,848
JBrowse link
G Cacng5 calcium voltage-gated channel auxiliary subunit gamma 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CACNG5 mRNA CTD PMID:18164116 NCBI chr10:96,122,240...96,166,606
Ensembl chr10:96,123,397...96,131,880
JBrowse link
G Car2 carbonic anhydrase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CA2 mRNA CTD PMID:18164116 NCBI chr 2:88,097,740...88,112,868
Ensembl chr 2:88,097,720...88,113,029
JBrowse link
G Casp1 caspase 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of CASP1 mRNA CTD PMID:19737606 NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
JBrowse link
G Casp3 caspase 3 multiple interactions EXP beta-Naphthoflavone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] CTD PMID:21947872 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Cav1 caveolin 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAV mRNA CTD PMID:18164116 NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
JBrowse link
G Cblc Cbl proto-oncogene C multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CBLC mRNA CTD PMID:18164116 NCBI chr 1:80,699,321...80,716,146
Ensembl chr 1:80,699,323...80,716,146
JBrowse link
G Cbr1 carbonyl reductase 1 increases expression
multiple interactions
ISO beta-Naphthoflavone results in increased expression of CBR1 mRNA
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA
CTD PMID:17569794, PMID:19737545, PMID:19737606 NCBI chr11:33,813,041...33,815,418
Ensembl chr11:33,845,463...33,847,793
JBrowse link
G Cbr3 carbonyl reductase 3 multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR3 mRNA CTD PMID:19737545 NCBI chr11:33,909,417...33,917,674
Ensembl chr11:33,909,439...33,917,674
JBrowse link
G Ccdc80 coiled-coil domain containing 80 decreases expression ISO beta-Naphthoflavone results in decreased expression of CCDC80 mRNA CTD PMID:23994337 NCBI chr11:60,645,660...60,679,249
Ensembl chr11:60,645,086...60,679,555
JBrowse link
G Ccdc85b coiled-coil domain containing 85B increases expression ISO beta-Naphthoflavone results in increased expression of CCDC85B mRNA CTD PMID:23994337 NCBI chr 1:220,835,647...220,837,220 JBrowse link
G Cckbr cholecystokinin B receptor multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCKBR mRNA CTD PMID:18164116 NCBI chr 1:170,262,218...170,272,298
Ensembl chr 1:170,262,156...170,272,298
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA]
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CCL2 mRNA
beta-Naphthoflavone results in increased expression of CCL2 mRNA
CTD PMID:19737545, PMID:21295105, PMID:22687991 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
JBrowse link
G Ccl6 chemokine (C-C motif) ligand 6 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CCL6 mRNA CTD PMID:18164116 NCBI chr10:70,798,118...70,802,750
Ensembl chr10:70,797,124...70,802,782
JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCN1 mRNA CTD PMID:18164116 NCBI chr 2:251,529,354...251,532,312
Ensembl chr 2:251,529,354...251,532,312
JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions
decreases expression
ISO
EXP
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CCN2 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCN2 mRNA
beta-Naphthoflavone results in decreased expression of CCN2 mRNA
CTD PMID:18164116, PMID:19737545, PMID:19737606, PMID:32151702 NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
JBrowse link
G Ccn5 cellular communication network factor 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCN5 mRNA CTD PMID:18164116 NCBI chr 3:160,207,969...160,219,316
Ensembl chr 3:160,207,913...160,219,331
JBrowse link
G Ccna2 cyclin A2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCNA2 mRNA CTD PMID:18164116 NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
JBrowse link
G Ccnb1 cyclin B1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCNB1 mRNA CTD PMID:18164116 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
JBrowse link
G Ccnd1 cyclin D1 decreases expression EXP beta-Naphthoflavone results in decreased expression of CCND1 mRNA CTD PMID:12883083 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
JBrowse link
G Cct3 chaperonin containing TCP1 subunit 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCT3 mRNA CTD PMID:18164116 NCBI chr 2:187,669,051...187,693,610
Ensembl chr 2:187,668,796...187,693,610
JBrowse link
G Cd24 CD24 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD24 mRNA CTD PMID:18164116 NCBI chr20:48,335,540...48,340,847
Ensembl chr20:48,335,540...48,340,846
JBrowse link
G Cd276 Cd276 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD276 mRNA CTD PMID:18164116 NCBI chr 8:63,312,060...63,350,411
Ensembl chr 8:63,318,019...63,350,269
JBrowse link
G Cd36 CD36 molecule increases expression ISO beta-Naphthoflavone results in increased expression of CD36 mRNA CTD PMID:23994337 NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
JBrowse link
G Cd38 CD38 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD38 mRNA CTD PMID:18164116 NCBI chr14:71,714,768...71,754,990
Ensembl chr14:71,715,269...71,754,672
JBrowse link
G Cd47 Cd47 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CD47 mRNA CTD PMID:18164116 NCBI chr11:53,511,485...53,575,754
Ensembl chr11:53,514,595...53,575,175
JBrowse link
G Cd48 Cd48 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD48 mRNA CTD PMID:18164116 NCBI chr13:90,116,601...90,140,371
Ensembl chr13:90,116,843...90,140,371
JBrowse link
G Cd52 CD52 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD52 mRNA CTD PMID:18164116 NCBI chr 5:152,322,910...152,324,469
Ensembl chr 5:152,322,916...152,324,469
JBrowse link
G Cd63 Cd63 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD63 mRNA CTD PMID:18164116 NCBI chr 7:3,320,250...3,335,583
Ensembl chr 7:3,320,103...3,335,582
JBrowse link
G Cd9 CD9 molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CD9 mRNA CTD PMID:18164116 NCBI chr 4:157,977,163...158,010,091
Ensembl chr 4:157,977,162...158,010,166
JBrowse link
G Cdc20 cell division cycle 20 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDC20 mRNA CTD PMID:18164116, PMID:21295105 NCBI chr 5:137,260,728...137,264,931
Ensembl chr 5:137,260,739...137,265,015
JBrowse link
G Cdc42bpa CDC42 binding protein kinase alpha multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDC42BPA mRNA CTD PMID:18164116 NCBI chr13:98,231,326...98,447,762
Ensembl chr13:98,231,326...98,447,762
JBrowse link
G Cdc42ep2 CDC42 effector protein 2 increases expression ISO beta-Naphthoflavone results in increased expression of CDC42EP2 mRNA CTD PMID:19737606 NCBI chr 1:221,272,349...221,281,252
Ensembl chr 1:221,272,353...221,281,180
JBrowse link
G Cdca5 cell division cycle associated 5 affects expression ISO beta-Naphthoflavone affects the expression of CDCA5 mRNA CTD PMID:23994337 NCBI chr 1:221,448,661...221,462,235
Ensembl chr 1:221,448,661...221,462,233
JBrowse link
G Cdca8 cell division cycle associated 8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDCA8 mRNA CTD PMID:18164116 NCBI chr 5:142,911,310...142,933,536
Ensembl chr 5:142,911,305...142,933,526
JBrowse link
G Cdh11 cadherin 11 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDH11 mRNA CTD PMID:18164116 NCBI chr19:2,391,181...2,551,245
Ensembl chr19:2,393,059...2,551,245
JBrowse link
G Cdh13 cadherin 13 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDH13 mRNA CTD PMID:18164116 NCBI chr19:50,848,793...51,971,618
Ensembl chr19:50,848,736...51,972,103
JBrowse link
G Cdh17 cadherin 17 multiple interactions EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDH17 mRNA
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CDH17 mRNA
CTD PMID:18164116, PMID:19737545 NCBI chr 5:25,354,187...25,443,675
Ensembl chr 5:25,391,115...25,443,718
JBrowse link
G Cdh3 cadherin 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDH3 mRNA CTD PMID:18164116 NCBI chr19:38,668,957...38,719,801
Ensembl chr19:38,669,230...38,719,677
JBrowse link
G Cdhr5 cadherin-related family member 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDHR5 mRNA CTD PMID:18164116 NCBI chr 1:214,255,118...214,263,848
Ensembl chr 1:214,255,110...214,263,581
JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDK1 mRNA CTD PMID:18164116 NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
JBrowse link
G Cdk13 cyclin-dependent kinase 13 increases expression ISO beta-Naphthoflavone results in increased expression of CDK13 mRNA CTD PMID:23994337 NCBI chr17:49,833,194...49,922,932
Ensembl chr17:49,833,400...49,921,550
JBrowse link
G Cdk5rap2 CDK5 regulatory subunit associated protein 2 increases expression ISO beta-Naphthoflavone results in increased expression of CDK5RAP2 mRNA CTD PMID:19737606 NCBI chr 5:86,387,238...86,554,108
Ensembl chr 5:86,387,078...86,554,102
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A decreases expression
multiple interactions
EXP beta-Naphthoflavone results in decreased expression of CDKN1A mRNA; beta-Naphthoflavone results in decreased expression of CDKN1A protein
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDKN1A mRNA
CTD PMID:18164116, PMID:19389873, PMID:22687991 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B increases expression
multiple interactions
EXP beta-Naphthoflavone results in increased expression of CDKN2B mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA]
CTD PMID:21295105, PMID:22687991 NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDR2 mRNA CTD PMID:18164116 NCBI chr 1:190,889,698...190,914,606
Ensembl chr 1:190,889,701...190,914,610
JBrowse link
G Cdx2 caudal type homeo box 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDX2 mRNA CTD PMID:18164116 NCBI chr12:9,464,026...9,470,565
Ensembl chr12:9,464,026...9,470,565
JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CEACAM1 mRNA CTD PMID:18164116 NCBI chr 1:82,327,955...82,344,345
Ensembl chr 1:82,327,955...82,344,345
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha decreases expression EXP beta-Naphthoflavone results in decreased expression of CEBPA mRNA; beta-Naphthoflavone results in decreased expression of CEBPA protein CTD PMID:19389873 NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
JBrowse link
G Cela1 chymotrypsin like elastase 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CELA1 mRNA CTD PMID:18164116 NCBI chr 7:142,305,337...142,318,621
Ensembl chr 7:142,305,338...142,318,620
JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CELSR1 mRNA CTD PMID:18164116 NCBI chr 7:126,774,010...126,914,085
Ensembl chr 7:126,775,516...126,913,585
JBrowse link
G Cenpi centromere protein I multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CENPI mRNA CTD PMID:18164116 NCBI chr  X:105,147,045...105,198,798
Ensembl chr  X:105,147,153...105,198,797
JBrowse link
G Cenpx centromere protein X increases expression ISO beta-Naphthoflavone results in increased expression of CENPX mRNA CTD PMID:23994337 NCBI chr10:109,890,904...109,893,804 JBrowse link
G Ces3a carboxylesterase 3a multiple interactions
decreases expression
ISO [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CES3 mRNA; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CES3 mRNA] CTD PMID:19737545, PMID:22234961 NCBI chr19:37,070,705...37,079,411 JBrowse link
G Cfap45 cilia and flagella associated protein 45 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CFAP45 mRNA CTD PMID:18164116 NCBI chr13:90,909,551...90,932,958
Ensembl chr13:90,909,486...90,932,961
JBrowse link
G Cfdp1 craniofacial development protein 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CFDP1 mRNA CTD PMID:18164116 NCBI chr19:43,989,596...44,078,320
Ensembl chr19:43,971,474...44,078,336
JBrowse link
G Ch25h cholesterol 25-hydroxylase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CH25H mRNA CTD PMID:18164116 NCBI chr 1:252,807,062...252,811,409
Ensembl chr 1:252,807,065...252,808,380
JBrowse link
G Chdh choline dehydrogenase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CHDH mRNA CTD PMID:18164116 NCBI chr16:6,078,083...6,109,386
Ensembl chr16:6,078,122...6,109,382
JBrowse link
G Chpf chondroitin polymerizing factor multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CHPF mRNA CTD PMID:18164116 NCBI chr 9:82,669,199...82,673,898
Ensembl chr 9:82,669,204...82,673,898
JBrowse link
G Chrnb1 cholinergic receptor nicotinic beta 1 subunit multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CHRNB1 mRNA CTD PMID:18164116 NCBI chr10:56,390,671...56,403,255
Ensembl chr10:56,390,671...56,403,188
JBrowse link
G Cish cytokine inducible SH2-containing protein multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CISH mRNA CTD PMID:19737545 NCBI chr 8:116,054,547...116,059,494
Ensembl chr 8:116,054,465...116,060,723
JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CITED2 mRNA CTD PMID:18164116 NCBI chr 1:12,823,363...12,825,806
Ensembl chr 1:12,823,363...12,825,786
JBrowse link
G Clcn5 chloride voltage-gated channel 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLCN5 mRNA CTD PMID:18164116 NCBI chr  X:16,170,585...16,196,691
Ensembl chr  X:16,050,780...16,196,789
JBrowse link
G Cldn1 claudin 1 multiple interactions
increases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLDN1 mRNA
beta-Naphthoflavone results in increased expression of CLDN1 mRNA
CTD PMID:18164116, PMID:32151702 NCBI chr11:77,815,216...77,830,373
Ensembl chr11:77,815,181...77,830,416
JBrowse link
G Cldn4 claudin 4 increases expression ISO beta-Naphthoflavone results in increased expression of CLDN4 mRNA CTD PMID:32151702 NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
JBrowse link
G Cldn7 claudin 7 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CLDN7 mRNA CTD PMID:18164116 NCBI chr10:56,576,326...56,578,632
Ensembl chr10:56,576,428...56,578,626
JBrowse link
G Clic1 chloride intracellular channel 1 increases expression ISO beta-Naphthoflavone results in increased expression of CLIC1 mRNA CTD PMID:19737606 NCBI chr20:5,040,314...5,049,166
Ensembl chr20:5,040,337...5,049,166
JBrowse link
G Clock clock circadian regulator multiple interactions ISO beta-Naphthoflavone inhibits the reaction [CLOCK protein binds to ARNTL protein]; beta-Naphthoflavone inhibits the reaction [CLOCK protein binds to PER1 promoter] CTD PMID:20106950 NCBI chr14:34,418,226...34,502,218
Ensembl chr14:34,446,616...34,502,218
JBrowse link
G Clpx caseinolytic mitochondrial matrix peptidase chaperone subunit X multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLPX mRNA CTD PMID:18164116 NCBI chr 8:70,789,137...70,843,133
Ensembl chr 8:70,789,256...70,843,123
JBrowse link
G Clybl citramalyl-CoA lyase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLYBL mRNA CTD PMID:18164116 NCBI chr15:108,608,203...108,838,222
Ensembl chr15:108,608,204...108,838,235
JBrowse link
G Cnfn cornifelin increases expression ISO beta-Naphthoflavone results in increased expression of CNFN mRNA CTD PMID:32151702 NCBI chr 1:82,234,032...82,236,602
Ensembl chr 1:82,234,032...82,236,179
JBrowse link
G Cnn2 calponin 2 multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CNN2 mRNA CTD PMID:19737545 NCBI chr 7:12,782,459...12,787,977
Ensembl chr 7:12,782,491...12,787,750
JBrowse link
G Cnn3 calponin 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CNN3 mRNA CTD PMID:18164116 NCBI chr 2:225,005,069...225,036,179
Ensembl chr 2:225,005,019...225,036,188
JBrowse link
G Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CNP1 mRNA CTD PMID:18164116 NCBI chr10:88,490,798...88,497,357
Ensembl chr10:88,490,798...88,497,356
JBrowse link
G Col16a1 collagen type XVI alpha 1 chain multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL16A1 mRNA CTD PMID:18164116 NCBI chr 5:148,257,030...148,311,645
Ensembl chr 5:148,257,642...148,311,645
JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL18A1 mRNA CTD PMID:18164116 NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858
JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions
affects expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL1A1 mRNA
beta-Naphthoflavone affects the expression of COL1A1 mRNA
CTD PMID:18164116, PMID:20045035, PMID:21295105, PMID:23994337 NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
JBrowse link
G Col27a1 collagen type XXVII alpha 1 chain multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL27A1 mRNA CTD PMID:18164116 NCBI chr 5:79,054,004...79,172,442
Ensembl chr 5:79,055,521...79,170,765
JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL4A1 mRNA CTD PMID:18164116 NCBI chr16:83,522,162...83,632,153
Ensembl chr16:83,522,162...83,632,153
JBrowse link
G Col6a2 collagen type VI alpha 2 chain multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL6A2 mRNA CTD PMID:18164116 NCBI chr20:12,773,472...12,801,179
Ensembl chr20:12,773,427...12,801,180
JBrowse link
G Colec12 collectin sub-family member 12 increases expression
multiple interactions
ISO
EXP
beta-Naphthoflavone results in increased expression of COLEC12 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COLEC12 mRNA
CTD PMID:18164116, PMID:19737606 NCBI chr18:867,048...1,054,047
Ensembl chr18:867,048...1,052,606
JBrowse link
G Coq10b coenzyme Q10B decreases expression
multiple interactions
ISO beta-Naphthoflavone results in decreased expression of COQ10B mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of COQ10B mRNA]
CTD PMID:22234961 NCBI chr 9:61,655,963...61,675,880
Ensembl chr 9:61,655,963...61,675,873
JBrowse link
G Coq8a coenzyme Q8A multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of COQ8A mRNA CTD PMID:18164116 NCBI chr13:98,451,629...98,480,438
Ensembl chr13:98,451,637...98,480,419
JBrowse link
G Cox6b2 cytochrome c oxidase subunit 6B2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COX6B2 mRNA CTD PMID:18164116 NCBI chr 1:72,661,099...72,662,436
Ensembl chr 1:72,661,211...72,662,434
JBrowse link
G Cpe carboxypeptidase E multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CPE mRNA CTD PMID:18164116 NCBI chr16:26,906,716...27,014,811
Ensembl chr16:26,906,716...27,014,813
JBrowse link
G Cpox coproporphyrinogen oxidase increases expression ISO beta-Naphthoflavone results in increased expression of CPOX mRNA CTD PMID:23994337 NCBI chr11:44,039,665...44,049,648
Ensembl chr11:44,039,669...44,049,648
JBrowse link
G Cpz carboxypeptidase Z multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CPZ mRNA CTD PMID:18164116 NCBI chr14:80,402,946...80,426,203
Ensembl chr14:80,403,001...80,426,245
JBrowse link
G Crat carnitine O-acetyltransferase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CRAT mRNA CTD PMID:18164116 NCBI chr 3:8,967,984...8,981,959
Ensembl chr 3:8,968,417...8,981,362
JBrowse link
G Crct1 cysteine-rich C-terminal 1 multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CRCT1 mRNA CTD PMID:19737545 Ensembl chr 2:193,330,397...193,330,699 JBrowse link
G Crem cAMP responsive element modulator increases expression
multiple interactions
ISO
EXP
beta-Naphthoflavone results in increased expression of CREM mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CREM mRNA
CTD PMID:18164116, PMID:19737606 NCBI chr17:57,021,704...57,090,888
Ensembl chr17:57,031,766...57,090,888
JBrowse link
G Crisp2 cysteine-rich secretory protein 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CRISP2 mRNA CTD PMID:18164116 NCBI chr 9:23,503,223...23,527,502
Ensembl chr 9:23,503,236...23,527,496
JBrowse link
G Crot carnitine O-octanoyltransferase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CROT mRNA CTD PMID:18164116 NCBI chr 4:22,079,837...22,116,265
Ensembl chr 4:22,081,604...22,116,265
JBrowse link
G Cryab crystallin, alpha B multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CRYAB mRNA CTD PMID:18164116 NCBI chr 8:55,178,543...55,182,546
Ensembl chr 8:55,178,289...55,182,545
JBrowse link
G Cryz crystallin zeta multiple interactions
increases expression
increases activity
ISO AHR protein promotes the reaction [beta-Naphthoflavone results in increased activity of CRYZ protein]; Copper inhibits the reaction [beta-Naphthoflavone results in increased activity of CRYZ protein]; Copper inhibits the reaction [beta-Naphthoflavone results in increased expression of CRYZ mRNA]; Lead inhibits the reaction [beta-Naphthoflavone results in increased expression of CRYZ mRNA]; Mercury promotes the reaction [beta-Naphthoflavone results in increased activity of CRYZ protein]; Mercury promotes the reaction [beta-Naphthoflavone results in increased expression of CRYZ mRNA] CTD PMID:15297030 NCBI chr 2:260,884,315...260,911,827
Ensembl chr 2:260,884,337...260,911,792
JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CSMD1 mRNA CTD PMID:18164116 NCBI chr16:77,152,823...78,850,222
Ensembl chr16:78,539,489...78,850,222
JBrowse link
G Csn2 casein beta multiple interactions
decreases expression
ISO AHR gene alternative form affects the reaction [beta-Naphthoflavone results in decreased expression of CSN2 mRNA]; beta-Naphthoflavone inhibits the reaction [[PRL protein co-treated with Dexamethasone] results in increased expression of CSN2 mRNA]
beta-Naphthoflavone results in decreased expression of CSN2 mRNA; beta-Naphthoflavone results in decreased expression of CSN2 protein
CTD PMID:29521512 NCBI chr14:21,972,274...21,979,511
Ensembl chr14:21,972,274...21,979,510
JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions ISO CTNNB1 gene mutant form affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; CTNNB1 gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] CTD PMID:25174530 NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
JBrowse link
G Ctsc cathepsin C multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CTSC mRNA CTD PMID:18164116 NCBI chr 1:151,918,514...151,949,979
Ensembl chr 1:151,918,571...151,949,983
JBrowse link
G Cul5 cullin 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CUL5 mRNA CTD PMID:18164116 NCBI chr 8:58,199,992...58,255,149
Ensembl chr 8:58,202,821...58,253,688
JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CX3CL1 mRNA CTD PMID:18164116 NCBI chr19:10,644,267...10,654,861
Ensembl chr19:10,644,244...10,653,800
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 increases expression ISO beta-Naphthoflavone results in increased expression of CXCL1 mRNA CTD PMID:32151702 NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
JBrowse link
G Cxcl11 C-X-C motif chemokine ligand 11 multiple interactions
increases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CXCL11 mRNA
beta-Naphthoflavone results in increased expression of CXCL11 mRNA
CTD PMID:18164116, PMID:32151702 NCBI chr14:17,195,395...17,198,170
Ensembl chr14:17,195,014...17,198,291
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 decreases expression ISO beta-Naphthoflavone results in decreased expression of CXCL12 mRNA CTD PMID:23994337 NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CXCL13 mRNA CTD PMID:19737545 NCBI chr14:15,253,146...15,258,221
Ensembl chr14:15,253,125...15,258,207
JBrowse link
G Cxcl16 C-X-C motif chemokine ligand 16 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CXCL16 mRNA CTD PMID:18164116 NCBI chr10:57,060,005...57,064,600
Ensembl chr10:57,060,007...57,064,600
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression ISO beta-Naphthoflavone results in increased expression of CXCL2 mRNA CTD PMID:32151702 NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression ISO beta-Naphthoflavone results in increased expression of CXCL1 mRNA CTD PMID:32151702 NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
JBrowse link
G Cyb5b cytochrome b5 type B decreases expression
multiple interactions
ISO beta-Naphthoflavone results in decreased expression of CYB5B mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYB5B mRNA]
CTD PMID:22234961 NCBI chr19:39,357,814...39,391,680
Ensembl chr19:39,357,791...39,393,189
JBrowse link
G Cyb5r2 cytochrome b5 reductase 2 increases expression ISO beta-Naphthoflavone results in increased expression of CYB5R2 mRNA CTD PMID:32151702 NCBI chr 1:171,971,424...171,981,586
Ensembl chr 1:171,971,701...171,979,933
JBrowse link
G Cygb cytoglobin multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYGB mRNA CTD PMID:18164116 NCBI chr10:105,618,325...105,628,091
Ensembl chr10:105,618,326...105,628,091
JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 increases expression
multiple interactions
ISO beta-Naphthoflavone results in increased expression of CYP11B1 mRNA
beta-Naphthoflavone promotes the reaction [CYP11B1 protein results in increased chemical synthesis of Hydrocortisone]
CTD PMID:22172629 NCBI chr 7:116,248,759...116,255,205
Ensembl chr 7:116,156,219...116,255,167
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CYP17A1 mRNA CTD PMID:19737545 NCBI chr 1:266,422,127...266,429,947
Ensembl chr 1:266,422,132...266,428,239
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 increases expression ISO beta-Naphthoflavone results in increased expression of CYP19A1 mRNA CTD PMID:19737606 NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 decreases activity
multiple interactions
increases activity
increases expression
ISO
EXP
beta-Naphthoflavone results in decreased activity of CYP1A1 protein
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A1 mRNA; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A1 protein; [Phenobarbital co-treated with beta-Naphthoflavone] results in increased expression of CYP1A1 protein; AHR protein promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Amiodarone promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone promotes the reaction [Diethylnitrosamine results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone results in increased expression of and results in increased activity of CYP1A1 protein; Curcumin inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Drugs, Chinese Herbal inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Genistein inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; Quercetin inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Resveratrol inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Silymarin inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Tamoxifen inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]
beta-Naphthoflavone results in increased expression of CYP1A1 mRNA; beta-Naphthoflavone results in increased expression of CYP1A1 protein
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A1 mRNA; [beta-Naphthoflavone binds to and affects the localization of AHR protein] promotes the reaction [[AHR protein binds to CYP1A1 enhancer] which results in increased expression of CYP1A1 mRNA]; [beta-Naphthoflavone binds to and affects the localization of AHR protein] which results in increased expression of CYP1A1 mRNA; [beta-Naphthoflavone results in increased expression of CYP1A2 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; [beta-Naphthoflavone results in increased expression of NQO1 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; Acetylcysteine affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Acetylcysteine affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [beta-Naphthoflavone results in decreased activity of CYP1A1 protein]; AHR affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; AHR gene alternative form affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; andrographolide promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Apigenin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Apigenin promotes the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; ARNT affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Arsenic inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Arsenic promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Arsenic promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; Ascorbic Acid affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Ascorbic Acid affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Berberine inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; beta-Naphthoflavone promotes the reaction [14-deoxy-11,12-didehydroandrographolide results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone promotes the reaction [[PRL protein co-treated with Dexamethasone] results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone promotes the reaction [andrographolide results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased activity of CYP1A1 protein]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 protein]; Buthionine Sulfoximine promotes the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Buthionine Sulfoximine promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Butylated Hydroxytoluene affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Cadmium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Cadmium promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Cadmium promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; Chromium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Chromium promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Chromium promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; chrysin promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Copper inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Copper inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Copper inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; CTNNB1 gene mutant form affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; CYP1A1 protein affects the reaction [beta-Naphthoflavone results in increased metabolism of Imiquimod]; Dactinomycin inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; FH535 inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; flavanone promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; galangin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Glutathione affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Glutathione affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Hydrogen Peroxide promotes the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Hydrogen Peroxide promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; kaempferol inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; kaempferol inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Lead inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Lead inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Lipopolysaccharides inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Luteolin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Mercury inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Mercury promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Mercury promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; morin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; myricetin inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; naringenin promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; neoandrographolide inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; Pregnenolone Carbonitrile inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Pregnenolone Carbonitrile inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; Quercetin inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]
3'-methoxy-4'-nitroflavone inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYP1A1 mRNA]; AHR protein affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; beta-Naphthoflavone promotes the reaction [Cycloheximide results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone promotes the reaction [Resveratrol results in increased expression of CYP1A1 protein]; beta-Naphthoflavone results in increased expression of and results in increased activity of CYP1A1 protein; CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 mRNA]]; CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]]; Resveratrol inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]
beta-Naphthoflavone results in increased expression of CYP1A1; beta-Naphthoflavone results in increased expression of CYP1A1 mRNA; beta-Naphthoflavone results in increased expression of CYP1A1 protein
beta-Naphthoflavone results in increased activity of CYP1A1 promoter; beta-Naphthoflavone results in increased activity of CYP1A1 protein
CTD PMID:1358564, PMID:2154339, PMID:3379039, PMID:3929785, PMID:7646562, PMID:7980650, PMID:8403195, PMID:8647108, PMID:8902619, PMID:9860486, PMID:9973208, PMID:10463385, PMID:10918498, PMID:10923861, PMID:11752103, PMID:12520768, PMID:12623754, PMID:12628514, PMID:12883083, PMID:14570766, PMID:15297030, PMID:15337587, PMID:15371557, PMID:15588932, PMID:15607757, PMID:15621696, PMID:15627257, PMID:15629189, PMID:15744758, PMID:15860653, PMID:15893423, PMID:15919853, PMID:15958656, PMID:16054776, PMID:16354159, PMID:16901605, PMID:16906435, PMID:16985168, PMID:17069994, PMID:17627975, PMID:17825862, PMID:18094037, PMID:18164116, PMID:18488193, PMID:18493746, PMID:18502397, PMID:19118567, PMID:19144771, PMID:19252307, PMID:19389873, PMID:19695238, PMID:19737545, PMID:19737606, PMID:19768707, PMID:19850099, PMID:19901195, PMID:19969063, PMID:20045035, PMID:20080079, PMID:20106950, PMID:20362646, PMID:20570689, PMID:20823264, PMID:20930378, PMID:21053930, PMID:21094198, PMID:21127131, PMID:21146967, PMID:21203749, PMID:21292640, PMID:21295105, PMID:21296134, PMID:21666223, PMID:21745492, PMID:21849270, PMID:21963808, PMID:22234961, PMID:22258563, PMID:22342832, PMID:22499231, PMID:22687991, PMID:22975028, PMID:23994337, PMID:24161567, PMID:24832110, PMID:25174530, PMID:25218365, PMID:25370011, PMID:25716673, PMID:25929820, PMID:26318284, PMID:26880746, PMID:27286660, PMID:28201809, PMID:28428138, PMID:28601433, PMID:28973660, PMID:29180065, PMID:29274324, PMID:29521512, PMID:30031879, PMID:30842367, PMID:31111189, PMID:31678242, PMID:32151702 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity
increases response to substance
increases activity
increases expression
multiple interactions
ISO
EXP
beta-Naphthoflavone results in decreased activity of CYP1A2 protein
CYP1A2 gene mutant form results in increased susceptibility to beta-Naphthoflavone
beta-Naphthoflavone results in increased activity of CYP1A2 protein
beta-Naphthoflavone results in increased expression of CYP1A2 mRNA; beta-Naphthoflavone results in increased expression of CYP1A2 protein
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA; [beta-Naphthoflavone results in increased expression of CYP1A2 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; [beta-Naphthoflavone results in increased expression of CYP1A2 protein] which results in decreased susceptibility to Oxygen; [furafylline results in decreased activity of CYP1A2 protein] promotes the reaction [beta-Naphthoflavone results in increased activity of AHR protein]; Berberine inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased activity of CYP1A2 protein]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A2 mRNA]; CTNNB1 gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA]; CYP1A2 protein affects the reaction [beta-Naphthoflavone results in increased metabolism of Imiquimod]; Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA]; Pregnenolone Carbonitrile inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA]
[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 protein; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA; [Phenobarbital co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 protein; beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; beta-Naphthoflavone results in increased expression of and results in increased activity of CYP1A2 protein; diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A2 protein]; lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein]
beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole]; CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 mRNA]]; CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]]; CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of NQO1 protein]]; CYP1A2 gene mutant form promotes the reaction [beta-Naphthoflavone results in increased expression of NQO1 mRNA]
CTD PMID:2208584, PMID:3038308, PMID:8419313, PMID:8902619, PMID:10463385, PMID:10923861, PMID:10936227, PMID:12584154, PMID:12623754, PMID:14722322, PMID:15466162, PMID:15607757, PMID:15629189, PMID:15855724, PMID:15893423, PMID:16054776, PMID:16354159, PMID:16985168, PMID:18164116, PMID:18493746, PMID:19041297, PMID:19118567, PMID:19252307, PMID:19497360, PMID:19497361, PMID:19695238, PMID:19737545, PMID:20045035, PMID:20362646, PMID:20448087, PMID:20607812, PMID:21053930, PMID:21745492, PMID:22258563, PMID:22342832, PMID:22491429, PMID:22499231, PMID:22687991, PMID:22843569, PMID:25174530, PMID:25218365, PMID:25370011, PMID:25512232, PMID:25929820, PMID:26201057, PMID:26827781, PMID:26880746, PMID:28201809, PMID:28428138, PMID:29180065, PMID:29366910, PMID:30842367, PMID:31111189, PMID:32151702 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
increases expression
ISO
EXP
beta-Naphthoflavone binds to and results in decreased activity of CYP1B1 protein
beta-Naphthoflavone results in increased expression of CYP1B1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1B1 mRNA
beta-Naphthoflavone results in increased expression of CYP1B1 mRNA; beta-Naphthoflavone results in increased expression of CYP1B1 protein
andrographolide promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA]; Apigenin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA]; Pregnenolone Carbonitrile inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA]
CTD PMID:12623754, PMID:14990334, PMID:16985168, PMID:18164116, PMID:19389873, PMID:19563207, PMID:19695238, PMID:19737545, PMID:19969063, PMID:20045035, PMID:20607812, PMID:20823264, PMID:20930378, PMID:21053930, PMID:22687991, PMID:25218365, PMID:25929820, PMID:28428138, PMID:28601433, PMID:32151702 NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
JBrowse link
G Cyp21a1 cytochrome P450, family 21, subfamily a, polypeptide 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP21A1 mRNA CTD PMID:18164116 NCBI chr20:4,486,213...4,489,358
Ensembl chr20:4,486,219...4,489,550
JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP26A1 mRNA CTD PMID:18164116 NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 increases expression ISO beta-Naphthoflavone results in increased expression of CYP27A1 mRNA CTD PMID:32151702 NCBI chr 9:81,968,285...81,998,213
Ensembl chr 9:81,968,332...81,998,169
JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 increases expression ISO beta-Naphthoflavone results in increased expression of CYP27B1 mRNA CTD PMID:32151702 NCBI chr 7:70,333,150...70,340,006
Ensembl chr 7:70,335,061...70,340,005
JBrowse link
G Cyp2a1 cytochrome P450, family 2, subfamily a, polypeptide 1 increases expression EXP beta-Naphthoflavone results in increased expression of CYP2A1 mRNA CTD PMID:19118567 NCBI chr 1:83,711,223...83,725,222
Ensembl chr 1:83,653,234...83,766,484
JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 increases expression ISO beta-Naphthoflavone results in increased expression of CYP2A5 mRNA CTD PMID:29788535 NCBI chr 1:83,653,248...83,662,118
Ensembl chr 1:83,653,234...83,766,484
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases activity
multiple interactions
increases expression
EXP
ISO
beta-Naphthoflavone results in increased activity of CYP2B1 protein
beta-Naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B1 protein]
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B10 mRNA
beta-Naphthoflavone results in increased expression of CYP2B1 mRNA; beta-Naphthoflavone results in increased expression of CYP2B1 protein
CTD PMID:15588932, PMID:15607757, PMID:16054776, PMID:19737545 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 multiple interactions
increases activity
decreases expression
EXP beta-Naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B2 protein]
beta-Naphthoflavone results in increased activity of CYP2B2 protein
beta-Naphthoflavone results in decreased expression of CYP2B2 mRNA
CTD PMID:16054776, PMID:20607812 NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions
increases activity
increases expression
ISO [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B9 mRNA
beta-Naphthoflavone results in increased activity of CYP2B6 protein
beta-Naphthoflavone results in increased expression of CYP2B9 mRNA
beta-Naphthoflavone results in increased expression of CYP2B6 mRNA
CTD PMID:19118567, PMID:19497361, PMID:19737545, PMID:22258563 NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP2C mRNA; [Phenobarbital co-treated with beta-Naphthoflavone] results in decreased expression of CYP2C11 protein CTD PMID:18164116, PMID:30842367 NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
JBrowse link
G Cyp2c24 cytochrome P450, family 2, subfamily c, polypeptide 24 decreases expression ISO beta-Naphthoflavone results in decreased expression of CYP2C18 mRNA CTD PMID:16985168 NCBI chr 1:258,074,797...258,139,176
Ensembl chr 1:258,074,860...258,139,176
JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 decreases expression
multiple interactions
ISO
EXP
beta-Naphthoflavone results in decreased expression of CYP2C19 mRNA
[Phenobarbital co-treated with beta-Naphthoflavone] results in increased expression of CYP2C6V1 protein
CTD PMID:16985168, PMID:30842367 NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
JBrowse link
G Cyp2c7 cytochrome P450, family 2, subfamily c, polypeptide 7 decreases expression
multiple interactions
EXP beta-Naphthoflavone results in decreased expression of CYP2C7 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP2C7 mRNA
CTD PMID:18164116, PMID:20607812 NCBI chr 1:147,422,999...148,119,979
Ensembl chr 1:148,053,687...148,119,857
JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 decreases expression ISO beta-Naphthoflavone results in decreased expression of CYP2D6 mRNA CTD PMID:22258563 NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases expression
multiple interactions
decreases expression
EXP
ISO
beta-Naphthoflavone results in increased expression of CYP2E1 mRNA
beta-Naphthoflavone results in increased expression of CYP2E1 mRNA; beta-Naphthoflavone results in increased expression of CYP2E1 protein
[Phenobarbital co-treated with beta-Naphthoflavone] results in decreased expression of CYP2E1 protein
beta-Naphthoflavone results in decreased expression of CYP2E1 mRNA
CTD PMID:19969063, PMID:22258563, PMID:30373287, PMID:30842367 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
JBrowse link
G Cyp2j3 cytochrome P450, family 2, subfamily j, polypeptide 3 increases expression EXP beta-Naphthoflavone results in increased expression of CYP2J3 mRNA CTD PMID:19969063 NCBI chr 5:115,196,982...115,222,084 JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 increases expression ISO beta-Naphthoflavone results in increased expression of CYP2S1 mRNA CTD PMID:23994337 NCBI chr 1:82,595,211...82,610,350
Ensembl chr 1:82,595,211...82,610,350
JBrowse link
G Cyp2u1 cytochrome P450, family 2, subfamily u, polypeptide 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP2U1 mRNA CTD PMID:18164116 NCBI chr 2:236,414,131...236,431,650
Ensembl chr 2:236,414,135...236,431,683
JBrowse link
G Cyp2w1 cytochrome P450, family 2, subfamily w, polypeptide 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of CYP2W1 mRNA CTD PMID:16985168 NCBI chr12:17,382,749...17,387,909
Ensembl chr12:17,383,159...17,387,879
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions
increases activity
EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP3A2 mRNA; [Phenobarbital co-treated with beta-Naphthoflavone] results in increased expression of CYP3A2 protein; diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP3A2 protein] CTD PMID:18164116, PMID:26880746, PMID:30842367 NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 decreases expression
multiple interactions
increases activity
EXP beta-Naphthoflavone results in decreased expression of CYP3A23-3A1 mRNA
[Phenobarbital co-treated with beta-Naphthoflavone] results in increased expression of CYP3A23-3A1 protein; diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP3A23-3A1 protein]
CTD PMID:19041297, PMID:26880746, PMID:30842367 NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP3A62 mRNA CTD PMID:18164116 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP3A13 mRNA CTD PMID:18164116 NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
JBrowse link
G Cyp4a1 cytochrome P450, family 4, subfamily a, polypeptide 1 increases expression EXP beta-Naphthoflavone results in increased expression of CYP4A1 mRNA CTD PMID:19969063 NCBI chr 5:134,492,734...134,507,158
Ensembl chr 5:134,492,756...134,507,154
JBrowse link
G Cyp4a8 cytochrome P450, family 4, subfamily a, polypeptide 8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP4A8 mRNA CTD PMID:18164116 NCBI chr 5:133,978,953...134,008,255
Ensembl chr 5:133,978,954...134,008,255
JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of CYP4B1 mRNA CTD PMID:16985168, PMID:22258563 NCBI chr 5:134,508,728...134,526,103
Ensembl chr 5:134,508,730...134,526,089
JBrowse link
G Cyp4f18 cytochrome P450, family 4, subfamily f, polypeptide 18 increases expression ISO beta-Naphthoflavone results in increased expression of CYP4F3 mRNA CTD PMID:28601433 NCBI chr16:19,501,680...19,528,935
Ensembl chr16:19,410,810...19,528,999
JBrowse link
G Cyp4f4 cytochrome P450, family 4, subfamily f, polypeptide 4 increases expression EXP beta-Naphthoflavone results in increased expression of CYP4F4 mRNA CTD PMID:19969063 NCBI chr 7:14,891,062...14,907,250
Ensembl chr 7:14,891,001...14,907,305
JBrowse link
G Cyp51 cytochrome P450, family 51 multiple interactions
decreases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP51 mRNA
beta-Naphthoflavone results in decreased expression of CYP51 mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYP51 mRNA]
CTD PMID:18164116, PMID:22234961 NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of CYP7A1 mRNA CTD PMID:22258563 NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431
JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 increases expression ISO beta-Naphthoflavone results in increased expression of CYP7B1 mRNA CTD PMID:22258563 NCBI chr 2:102,701,903...102,871,257
Ensembl chr 2:102,701,903...102,871,257
JBrowse link
G Dbn1 drebrin 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DBN1 mRNA CTD PMID:18164116 NCBI chr17:9,679,511...9,693,878
Ensembl chr17:9,679,628...9,693,820
JBrowse link
G Dbp D-box binding PAR bZIP transcription factor multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DBP mRNA CTD PMID:18164116 NCBI chr 1:101,687,896...101,692,845
Ensembl chr 1:101,687,855...101,692,846
JBrowse link
G Dclk1 doublecortin-like kinase 1 multiple interactions
increases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DCLK1 mRNA
beta-Naphthoflavone results in increased expression of DCLK1 mRNA
CTD PMID:18164116, PMID:23994337 NCBI chr 2:144,646,255...144,939,389
Ensembl chr 2:144,646,308...144,936,927
JBrowse link
G Dcn decorin decreases expression ISO beta-Naphthoflavone results in decreased expression of DCN mRNA CTD PMID:23994337 NCBI chr 7:38,742,250...38,782,282
Ensembl chr 7:38,742,051...38,782,323
JBrowse link
G Ddc dopa decarboxylase multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of DDC mRNA CTD PMID:19737545 NCBI chr14:91,905,919...91,996,816
Ensembl chr14:91,905,919...91,996,774
JBrowse link
G Defb1 defensin beta 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of DEFB1 mRNA CTD PMID:19737606 NCBI chr16:75,294,385...75,309,127
Ensembl chr16:75,294,376...75,309,176
JBrowse link
G Depp1 DEPP1, autophagy regulator increases expression ISO beta-Naphthoflavone results in increased expression of DEPP1 mRNA CTD PMID:17175557 NCBI chr 4:148,780,330...148,784,566
Ensembl chr 4:148,782,479...148,784,562
JBrowse link
G Dgat2 diacylglycerol O-acyltransferase 2 decreases expression ISO beta-Naphthoflavone results in decreased expression of DGAT2 mRNA CTD PMID:19737606 NCBI chr 1:164,113,459...164,143,818
Ensembl chr 1:164,113,459...164,143,818
JBrowse link
G Dhcr7 7-dehydrocholesterol reductase multiple interactions
decreases expression
ISO AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of DHCR7 mRNA] CTD PMID:22234961 NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
JBrowse link
G Dio2 iodothyronine deiodinase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DIO2 mRNA CTD PMID:18164116 NCBI chr 6:114,475,156...114,489,443
Ensembl chr 6:114,476,142...114,476,723
JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of DKK1 mRNA CTD PMID:19737606 NCBI chr 1:248,952,896...248,956,579
Ensembl chr 1:248,895,738...248,898,607
JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DMBT1 mRNA CTD PMID:18164116 NCBI chr 1:201,620,642...201,689,905
NCBI chr 1:203,149,414...203,228,705
JBrowse link
G Dmgdh dimethylglycine dehydrogenase decreases expression
multiple interactions
ISO beta-Naphthoflavone results in decreased expression of DMGDH mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of DMGDH mRNA]
CTD PMID:22234961 NCBI chr 2:23,289,376...23,370,360
Ensembl chr 2:23,289,374...23,370,477
JBrowse link
G Dnah9 dynein, axonemal, heavy chain 9 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DNAH9 mRNA CTD PMID:18164116 NCBI chr10:52,351,226...52,711,289
Ensembl chr10:52,351,192...52,710,862
JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 increases expression ISO beta-Naphthoflavone results in increased expression of DNAJB11 mRNA CTD PMID:23994337 NCBI chr11:81,741,342...81,757,806
Ensembl chr11:81,741,297...81,757,813
JBrowse link
G Dnm1 dynamin 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DNM1 mRNA CTD PMID:18164116 NCBI chr 3:11,338,081...11,382,043
Ensembl chr 3:11,338,083...11,382,043
JBrowse link
G Dnm1l dynamin 1-like multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DNM1L mRNA CTD PMID:18164116 NCBI chr11:88,830,968...88,882,271
Ensembl chr11:88,830,957...88,880,198
JBrowse link
G Dock9 dedicator of cytokinesis 9 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DOCK9 mRNA CTD PMID:18164116 NCBI chr15:107,945,664...108,210,967
Ensembl chr15:107,945,664...108,210,826
JBrowse link
G Dpep1 dipeptidase 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DPEP1 mRNA CTD PMID:18164116 NCBI chr19:55,973,447...55,998,830
Ensembl chr19:55,982,740...55,998,208
JBrowse link
G Dpp7 dipeptidylpeptidase 7 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DPP7 mRNA CTD PMID:18164116 NCBI chr 3:2,569,135...2,573,387
Ensembl chr 3:2,569,135...2,573,387
JBrowse link
G Dtnb dystrobrevin, beta multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DTNB mRNA CTD PMID:18164116 NCBI chr 6:27,975,302...28,177,236
Ensembl chr 6:27,975,417...28,177,214
JBrowse link
G Dusp13 dual specificity phosphatase 13 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DUSP13 mRNA CTD PMID:18164116 NCBI chr15:2,524,435...2,541,734
Ensembl chr15:2,526,368...2,541,729
Ensembl chr15:2,526,368...2,541,729
Ensembl chr15:2,526,368...2,541,729
JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression ISO beta-Naphthoflavone results in increased expression of DUSP6 mRNA CTD PMID:19737606 NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
JBrowse link
G Dxo decapping exoribonuclease multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DXO mRNA CTD PMID:18164116 NCBI chr20:4,517,307...4,519,391
Ensembl chr20:4,517,307...4,519,389
JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 increases expression ISO beta-Naphthoflavone results in increased expression of DYNC1H1 mRNA CTD PMID:19737606 NCBI chr 6:134,958,854...135,085,769
Ensembl chr 6:134,958,854...135,085,769
JBrowse link
G Dysf dysferlin increases expression ISO beta-Naphthoflavone results in increased expression of DYSF mRNA CTD PMID:23994337 NCBI chr 4:115,700,942...115,901,873
Ensembl chr 4:115,712,850...115,901,873
JBrowse link
G Dzip1l DAZ interacting zinc finger protein 1-like multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DZIP1L mRNA CTD PMID:18164116 NCBI chr 8:107,875,659...107,916,298
Ensembl chr 8:107,875,991...107,916,294
JBrowse link
G Efemp2 EGF containing fibulin extracellular matrix protein 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EFEMP2 mRNA CTD PMID:18164116 NCBI chr 1:220,853,695...220,861,420
Ensembl chr 1:220,854,403...220,861,420
JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EGLN3 mRNA CTD PMID:18164116 NCBI chr 6:75,050,329...75,075,795
Ensembl chr 6:75,050,329...75,075,795
JBrowse link
G Egr1 early growth response 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EGR1 mRNA CTD PMID:18164116 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
JBrowse link
G Ehd2 EH-domain containing 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EHD2 mRNA CTD PMID:18164116 NCBI chr 1:77,847,599...77,865,870
Ensembl chr 1:77,847,600...77,865,870
JBrowse link
G Ehd4 EH-domain containing 4 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EHD4 mRNA CTD PMID:18164116 NCBI chr 3:111,877,853...111,941,841
Ensembl chr 3:111,877,853...111,941,841
JBrowse link
G Eid3 EP300 interacting inhibitor of differentiation 3 multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of EID3 mRNA CTD PMID:19737545 NCBI chr 7:26,976,154...26,977,479 JBrowse link
G Eln elastin multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ELN mRNA CTD PMID:18164116 NCBI chr12:24,978,478...25,021,864
Ensembl chr12:24,978,483...25,021,863
JBrowse link
G Elovl3 ELOVL fatty acid elongase 3 decreases expression ISO beta-Naphthoflavone results in decreased expression of ELOVL3 mRNA CTD PMID:28973660 NCBI chr 1:265,883,353...265,887,181
Ensembl chr 1:265,883,355...265,887,226
JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 decreases expression ISO beta-Naphthoflavone results in decreased expression of ELOVL6 mRNA CTD PMID:31225620 NCBI chr 2:234,187,490...234,296,124
Ensembl chr 2:234,189,105...234,296,145
Ensembl chr 2:234,189,105...234,296,145
JBrowse link
G Emilin1 elastin microfibril interfacer 1 increases expression ISO beta-Naphthoflavone results in increased expression of EMILIN1 mRNA CTD PMID:19737606 NCBI chr 6:26,821,249...26,829,013
Ensembl chr 6:26,821,255...26,828,972
JBrowse link
G Emp1 epithelial membrane protein 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EMP1 mRNA CTD PMID:18164116 NCBI chr 4:169,161,076...169,181,967
Ensembl chr 4:169,147,243...169,181,966
JBrowse link
G Emp3 epithelial membrane protein 3 increases expression ISO beta-Naphthoflavone results in increased expression of EMP3 mRNA CTD PMID:19737606 NCBI chr 1:101,900,731...101,903,948
Ensembl chr 1:101,900,733...101,903,910
JBrowse link
G Enc1 ectodermal-neural cortex 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ENC1 mRNA CTD PMID:18164116 NCBI chr 2:28,049,217...28,061,023
Ensembl chr 2:28,049,217...28,061,029
JBrowse link
G Enpp5 ectonucleotide pyrophosphatase/phosphodiesterase family member 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ENPP5 mRNA CTD PMID:18164116 NCBI chr 9:19,469,276...19,476,684
Ensembl chr 9:19,469,706...19,476,646
JBrowse link
G Entpd2 ectonucleoside triphosphate diphosphohydrolase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ENTPD2 mRNA CTD PMID:18164116 NCBI chr 3:2,617,795...2,623,818
Ensembl chr 3:2,617,805...2,623,445
JBrowse link
G Epcam epithelial cell adhesion molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EPCAM mRNA CTD PMID:18164116 NCBI chr 6:11,282,194...11,308,870
Ensembl chr 6:11,281,964...11,298,216
JBrowse link
G Epdr1 ependymin related 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EPDR1 mRNA CTD PMID:18164116 NCBI chr17:47,397,558...47,422,183
Ensembl chr17:47,397,558...47,422,182
JBrowse link
G Ephx1 epoxide hydrolase 1 decreases activity
increases expression
ISO beta-Naphthoflavone results in decreased activity of EPHX1 protein
beta-Naphthoflavone results in increased expression of EPHX1 mRNA
CTD PMID:3621371, PMID:22258563, PMID:23994337 NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
JBrowse link
G Eps15 epidermal growth factor receptor pathway substrate 15 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EPS15 mRNA CTD PMID:18164116 NCBI chr 5:128,923,809...129,022,268
Ensembl chr 5:128,923,934...129,022,054
JBrowse link
G Esm1 endothelial cell-specific molecule 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ESM1 mRNA CTD PMID:18164116 NCBI chr 2:45,104,392...45,113,130
Ensembl chr 2:45,104,305...45,113,131
JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
decreases expression
affects binding
EXP
ISO
[alpha-naphthoflavone co-treated with beta-Naphthoflavone] results in decreased expression of ESR1 mRNA
beta-Naphthoflavone results in decreased expression of ESR1 mRNA
[beta-Naphthoflavone binds to AHR protein] which binds to ESR1 protein
CTD PMID:10620335, PMID:20607812, PMID:22975028 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Esr2 estrogen receptor 2 multiple interactions EXP [alpha-naphthoflavone co-treated with beta-Naphthoflavone] results in decreased expression of ESR2 mRNA CTD PMID:22975028 NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
JBrowse link
G Esrra estrogen related receptor, alpha affects binding ISO [beta-Naphthoflavone binds to AHR protein] which binds to ESRRA protein CTD PMID:10620335 NCBI chr 1:222,168,729...222,178,842
Ensembl chr 1:222,168,730...222,178,725
JBrowse link
G Ezr ezrin multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EZR mRNA CTD PMID:18164116 NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FABP4 mRNA CTD PMID:18164116 NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
JBrowse link
G Fads1 fatty acid desaturase 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FADS1 mRNA CTD PMID:18164116 NCBI chr 1:226,234,034...226,249,118
Ensembl chr 1:226,234,074...226,249,138
JBrowse link
G Fam214b family with sequence similarity 214, member B increases expression ISO beta-Naphthoflavone results in increased expression of FAM214B mRNA CTD PMID:23994337 NCBI chr 5:58,477,894...58,484,900
Ensembl chr 5:58,477,894...58,484,900
JBrowse link
G Far1 fatty acyl CoA reductase 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FAR1 mRNA CTD PMID:18164116 NCBI chr 1:178,351,674...178,412,838
Ensembl chr 1:178,351,680...178,431,395
JBrowse link
G Faslg Fas ligand multiple interactions ISO AHR mutant form inhibits the reaction [beta-Naphthoflavone results in increased activity of [FASLG protein binds to FASLG protein]]; beta-Naphthoflavone results in increased activity of [FASLG protein binds to FASLG protein] CTD PMID:22951985 NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
JBrowse link
G Fasn fatty acid synthase decreases expression ISO beta-Naphthoflavone results in decreased expression of FASN mRNA CTD PMID:31225620 NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
JBrowse link
G Fblim1 filamin binding LIM protein 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FBLIM1 mRNA CTD PMID:18164116 NCBI chr 5:160,122,466...160,158,921
Ensembl chr 5:160,122,425...160,158,386
JBrowse link
G Fbln2 fibulin 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FBLN2 mRNA CTD PMID:18164116 NCBI chr 4:122,835,237...122,895,127
Ensembl chr 4:122,835,436...122,895,121
JBrowse link
G Fbln5 fibulin 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FBLN5 mRNA CTD PMID:18164116 NCBI chr 6:125,644,797...125,723,957
Ensembl chr 6:125,644,804...125,723,944
JBrowse link
G Fbxo21 F-box protein 21 increases expression ISO beta-Naphthoflavone results in increased expression of FBXO21 mRNA CTD PMID:23994337 NCBI chr12:44,244,633...44,279,044
Ensembl chr12:44,246,508...44,279,002
JBrowse link
G Fbxo25 F-box protein 25 increases expression ISO beta-Naphthoflavone results in increased expression of FBXO25 mRNA CTD PMID:19737606 NCBI chr16:80,770,788...80,806,661
Ensembl chr16:80,771,596...80,798,041
JBrowse link
G Fcna ficolin A multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of FCNA mRNA CTD PMID:18164116 NCBI chr 3:2,850,006...2,853,230
Ensembl chr 3:2,849,984...2,853,272
JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 decreases expression
multiple interactions
ISO beta-Naphthoflavone results in decreased expression of FDFT1 mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of FDFT1 mRNA]
CTD PMID:22234961 NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO beta-Naphthoflavone results in decreased expression of FDPS mRNA CTD PMID:31225620 NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
JBrowse link
G Fdx1 ferredoxin 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of FDX1 mRNA CTD PMID:18164116 NCBI chr 8:56,373,729...56,393,199
Ensembl chr 8:56,373,723...56,393,233
JBrowse link
G Fgb fibrinogen beta chain decreases expression ISO beta-Naphthoflavone results in decreased expression of FGB mRNA CTD PMID:19737606 NCBI chr 2:182,028,044...182,035,026
Ensembl chr 2:182,027,115...182,038,178
JBrowse link
G Fgd5 FYVE, RhoGEF and PH domain containing 5 increases expression ISO beta-Naphthoflavone results in increased expression of FGD5 mRNA CTD PMID:23994337 NCBI chr 4:123,865,557...123,962,904
Ensembl chr 4:123,865,725...123,962,881
JBrowse link
G Fgf21 fibroblast growth factor 21 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of FGF21 mRNA CTD PMID:18164116 NCBI chr 1:101,595,579...101,596,822
Ensembl chr 1:101,595,579...101,596,822
JBrowse link
G Fhl1 four and a half LIM domains 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FHL1 mRNA CTD PMID:18164116 NCBI chr  X:159,112,516...159,172,528
Ensembl chr  X:159,112,880...159,172,524
JBrowse link
G Fhl2 four and a half LIM domains 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FHL2 mRNA CTD PMID:18164116 NCBI chr 9:49,920,611...49,994,906
Ensembl chr 9:49,920,854...49,950,093
JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FKBP5 mRNA CTD PMID:18164116 NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020
JBrowse link
G Flg filaggrin decreases expression ISO beta-Naphthoflavone results in decreased expression of FLG protein CTD PMID:24161567 NCBI chr 2:193,565,401...193,574,297 JBrowse link
G Flnc filamin C increases expression ISO beta-Naphthoflavone results in increased expression of FLNC mRNA CTD PMID:19737606 NCBI chr 4:56,710,934...56,738,779
Ensembl chr 4:56,711,049...56,738,791
JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of FMO1 mRNA CTD PMID:22258563 NCBI chr13:80,712,885...80,745,095
Ensembl chr13:80,712,882...80,745,347
JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FMO2 mRNA CTD PMID:18164116 NCBI chr13:80,752,526...80,775,264
Ensembl chr13:80,755,058...80,775,264
JBrowse link
G Fmo5 flavin containing dimethylaniline monoxygenase 5 multiple interactions
decreases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FMO5 mRNA
beta-Naphthoflavone results in decreased expression of FMO5 mRNA
CTD PMID:18164116, PMID:22258563 NCBI chr 2:199,796,870...199,823,927
Ensembl chr 2:199,796,881...199,823,927
JBrowse link
G Fndc1 fibronectin type III domain containing 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FNDC1 mRNA CTD PMID:18164116 NCBI chr 1:47,605,211...47,687,499
Ensembl chr 1:47,605,262...47,687,504
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FOS mRNA
beta-Naphthoflavone results in increased expression of FOS mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of FOS protein]; beta-Naphthoflavone results in decreased expression of and results in increased ubiquitination of FOS protein; UBE2L3 protein affects the reaction [beta-Naphthoflavone results in decreased expression of FOS protein]
beta-Naphthoflavone promotes the reaction [FOS protein binds to NQO1 promoter]
CTD PMID:8375015, PMID:18164116, PMID:26318284, PMID:32151702 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit increases expression ISO beta-Naphthoflavone results in increased expression of FOSB mRNA CTD PMID:32151702 NCBI chr 1:80,214,691...80,221,417
Ensembl chr 1:80,214,494...80,221,710
JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FOSL1 mRNA CTD PMID:18164116 NCBI chr 1:220,826,560...220,835,066
Ensembl chr 1:220,826,560...220,835,066
JBrowse link
G Frzb frizzled-related protein multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FRZB mRNA CTD PMID:18164116 NCBI chr 3:67,635,604...67,668,772
Ensembl chr 3:67,635,607...67,668,772
JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions EXP beta-Naphthoflavone inhibits the reaction [FSHB protein results in increased expression of LHCGR mRNA] CTD PMID:26923738 NCBI chr 3:98,088,321...98,092,131
Ensembl chr 3:98,088,324...98,092,131
JBrowse link
G Fstl1 follistatin-like 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FSTL1 mRNA CTD PMID:18164116 NCBI chr11:65,791,196...65,845,721
Ensembl chr11:65,782,567...65,845,418
JBrowse link
G G0s2 G0/G1switch 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of G0S2 mRNA CTD PMID:18164116 NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
JBrowse link
G G6pd glucose-6-phosphate dehydrogenase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of G6PD protein CTD PMID:28903497 NCBI chr  X:156,274,800...156,293,935
Ensembl chr  X:156,274,800...156,293,926
JBrowse link
G Gabarapl1 GABA type A receptor associated protein like 1 increases expression ISO beta-Naphthoflavone results in increased expression of GABARAPL1 mRNA CTD PMID:19737606 NCBI chr 4:163,293,724...163,302,866
Ensembl chr 4:163,293,724...163,302,858
JBrowse link
G Gabrg1 gamma-aminobutyric acid type A receptor subunit gamma 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GABRG1 mRNA CTD PMID:18164116 NCBI chr14:39,964,502...40,051,306
Ensembl chr14:39,964,588...40,049,354
JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GADD45B mRNA CTD PMID:18164116 NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322
JBrowse link
G Galnt10 polypeptide N-acetylgalactosaminyltransferase 10 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GALNT10 mRNA CTD PMID:18164116 NCBI chr10:43,067,316...43,208,992
Ensembl chr10:43,067,299...43,210,427
JBrowse link
G Galr2 galanin receptor 2 increases expression ISO beta-Naphthoflavone results in increased expression of GALR2 mRNA CTD PMID:19737606 NCBI chr10:105,156,793...105,159,221
Ensembl chr10:105,156,632...105,237,611
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase increases expression ISO beta-Naphthoflavone results in increased expression of GAPDH mRNA CTD PMID:19850099 NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
JBrowse link
G Gas1 growth arrest-specific 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of GAS1 mRNA CTD PMID:23994337 NCBI chr17:4,846,116...4,849,350
Ensembl chr17:4,846,789...4,847,940
JBrowse link
G Gata3 GATA binding protein 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GATA3 mRNA CTD PMID:18164116 NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
JBrowse link
G Gba2 glucosylceramidase beta 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GBA2 mRNA CTD PMID:18164116 NCBI chr 5:59,068,081...59,079,719
Ensembl chr 5:59,068,081...59,079,719
JBrowse link
G Gcgr glucagon receptor decreases expression ISO beta-Naphthoflavone results in decreased expression of GCGR mRNA CTD PMID:23994337 NCBI chr10:109,707,863...109,716,253
Ensembl chr10:109,707,962...109,716,128
JBrowse link
G Gck glucokinase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GCK mRNA CTD PMID:18164116 NCBI chr14:86,149,146...86,191,589
Ensembl chr14:86,148,928...86,190,659
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression ISO beta-Naphthoflavone results in increased expression of GCLC mRNA CTD PMID:16426233, PMID:23994337 NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression
multiple interactions
ISO beta-Naphthoflavone results in increased expression of GCLM mRNA
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GCLM mRNA
CTD PMID:19737545, PMID:19737606 NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type increases expression ISO beta-Naphthoflavone results in increased expression of GCNT3 mRNA CTD PMID:19737606 NCBI chr 8:76,449,078...76,459,431
Ensembl chr 8:76,449,081...76,452,554
JBrowse link
G Gdf11 growth differentiation factor 11 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GDF11 mRNA CTD PMID:18164116 NCBI chr 7:3,306,863...3,315,856
Ensembl chr 7:3,306,863...3,315,856
JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO beta-Naphthoflavone results in increased expression of GDF15 mRNA CTD PMID:19737606 NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
JBrowse link
G Gdf6 growth differentiation factor 6 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GDF6 mRNA CTD PMID:18164116 NCBI chr 5:23,056,345...23,072,666
Ensembl chr 5:23,056,347...23,074,599
JBrowse link
G Gfer growth factor, augmenter of liver regeneration multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GFER mRNA CTD PMID:18164116 NCBI chr10:14,059,347...14,061,703
Ensembl chr10:14,059,347...14,061,703
JBrowse link
G Gja5 gap junction protein, alpha 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GJA5 mRNA CTD PMID:18164116 NCBI chr 2:199,162,745...199,184,942
Ensembl chr 2:199,162,745...199,184,939
JBrowse link
G Gkn1 gastrokine 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GKN1 mRNA CTD PMID:18164116 NCBI chr 4:119,143,070...119,148,358
Ensembl chr 4:119,143,070...119,148,358
JBrowse link
G Gla galactosidase, alpha increases expression ISO beta-Naphthoflavone results in increased expression of GLA mRNA CTD PMID:19737606 NCBI chr  X:105,405,915...105,417,331
Ensembl chr  X:105,406,792...105,417,323
JBrowse link
G Gls2 glutaminase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GLS2 mRNA CTD PMID:18164116 NCBI chr 7:2,605,679...2,621,853
Ensembl chr 7:2,605,719...2,621,852
JBrowse link
G Glul glutamate-ammonia ligase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GLUL mRNA CTD PMID:18164116 NCBI chr13:71,331,052...71,340,207
Ensembl chr13:71,331,052...71,340,229
JBrowse link
G Gmds GDP-mannose 4, 6-dehydratase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GMDS mRNA CTD PMID:18164116 NCBI chr17:33,408,722...33,938,086
Ensembl chr17:33,408,722...33,938,085
JBrowse link
G Gng8 G protein subunit gamma 8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GNG8 mRNA CTD PMID:18164116 NCBI chr 1:78,818,360...78,822,224
Ensembl chr 1:78,818,404...78,822,224
JBrowse link
G Gnpda1 glucosamine-6-phosphate deaminase 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of GNPDA1 mRNA CTD PMID:23994337 NCBI chr18:31,479,117...31,489,154
Ensembl chr18:31,479,117...31,487,671
JBrowse link
G Golga3 golgin A3 decreases expression ISO beta-Naphthoflavone results in decreased expression of GOLGA3 mRNA CTD PMID:23994337 NCBI chr12:52,510,509...52,558,606
Ensembl chr12:52,512,970...52,558,606
JBrowse link
G Gpam glycerol-3-phosphate acyltransferase, mitochondrial multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GPAM mRNA CTD PMID:18164116 NCBI chr 1:275,843,823...275,906,880
Ensembl chr 1:275,846,819...275,906,686
JBrowse link
G Gpbar1 G protein-coupled bile acid receptor 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPBAR1 mRNA CTD PMID:18164116 NCBI chr 9:81,555,914...81,560,931
Ensembl chr 9:81,559,605...81,560,594
JBrowse link
G Gpc3 glypican 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPC3 mRNA CTD PMID:18164116 NCBI chr  X:139,579,268...139,947,093
Ensembl chr  X:139,579,268...139,916,883
JBrowse link
G Gpd2 glycerol-3-phosphate dehydrogenase 2 decreases expression ISO beta-Naphthoflavone results in decreased expression of GPD2 mRNA CTD PMID:23994337 NCBI chr 3:43,223,892...43,359,069
Ensembl chr 3:43,255,567...43,359,074
JBrowse link
G Gpm6a glycoprotein m6a multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPM6A mRNA CTD PMID:18164116 NCBI chr16:39,367,697...39,719,292
Ensembl chr16:39,367,692...39,719,187
JBrowse link
G Gpm6b glycoprotein m6b multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPM6B mRNA CTD PMID:18164116 NCBI chr  X:29,604,607...29,751,174
Ensembl chr  X:29,607,075...29,648,403
JBrowse link
G Gpr35 G protein-coupled receptor 35 increases expression ISO beta-Naphthoflavone results in increased expression of GPR35 mRNA CTD PMID:23994337 NCBI chr 9:100,129,428...100,141,269
Ensembl chr 9:100,137,881...100,138,801
JBrowse link
G Gprc5c G protein-coupled receptor, class C, group 5, member C increases expression ISO beta-Naphthoflavone results in increased expression of GPRC5C mRNA CTD PMID:19737606 NCBI chr10:103,395,222...103,417,360
Ensembl chr10:103,395,511...103,417,358
JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GPT mRNA CTD PMID:18164116 NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GPX1 mRNA CTD PMID:18164116 NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression
multiple interactions
EXP beta-Naphthoflavone results in increased expression of GPX2 mRNA; beta-Naphthoflavone results in increased expression of GPX2 protein
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPX2 mRNA
CTD PMID:18164116, PMID:19389873, PMID:20045035, PMID:21203749, PMID:22687991 NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
JBrowse link
G Gpx3 glutathione peroxidase 3 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPX3 mRNA CTD PMID:18164116 NCBI chr10:40,247,436...40,255,423
Ensembl chr10:40,247,436...40,255,422
JBrowse link
G Gpx6 glutathione peroxidase 6 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPX6 mRNA CTD PMID:18164116 NCBI chr17:45,439,268...45,446,952
Ensembl chr17:45,439,268...45,446,907
JBrowse link
G Grb7 growth factor receptor bound protein 7 decreases expression ISO beta-Naphthoflavone results in decreased expression of GRB7 mRNA CTD PMID:19737606 NCBI chr10:86,393,186...86,408,893
Ensembl chr10:86,399,827...86,409,348
JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GRIA1 mRNA CTD PMID:18164116 NCBI chr10:42,441,723...42,760,200
Ensembl chr10:42,614,713...42,760,200
JBrowse link
G Grm7 glutamate metabotropic receptor 7 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GRM7 mRNA CTD PMID:18164116 NCBI chr 4:142,452,616...143,368,460
Ensembl chr 4:142,780,987...143,367,578
JBrowse link
G Gsdmd gasdermin D increases expression ISO beta-Naphthoflavone results in increased expression of GSDMD mRNA CTD PMID:23994337 NCBI chr 7:116,889,147...116,894,134
Ensembl chr 7:116,889,572...116,894,134
JBrowse link
G Gsta1 glutathione S-transferase alpha 1 decreases expression ISO beta-Naphthoflavone results in decreased expression of GSTA1 mRNA CTD PMID:25218365 NCBI chr 9:27,366,404...27,381,004
Ensembl chr 9:27,368,272...27,452,902
JBrowse link
G Gsta2 glutathione S-transferase alpha 2 increases expression
multiple interactions
increases activity
ISO
EXP
beta-Naphthoflavone results in increased expression of GSTA1 protein; beta-Naphthoflavone results in increased expression of GSTA2 mRNA; beta-Naphthoflavone results in increased expression of GSTA2 protein
Copper inhibits the reaction [beta-Naphthoflavone results in increased expression of GSTA2 mRNA]; Copper promotes the reaction [beta-Naphthoflavone results in increased activity of GSTA2 protein]; Lead inhibits the reaction [beta-Naphthoflavone results in increased activity of GSTA2 protein]; Lead inhibits the reaction [beta-Naphthoflavone results in increased expression of GSTA2 mRNA]; Lipopolysaccharides inhibits the reaction [beta-Naphthoflavone results in increased expression of GSTA1 mRNA]; Mercury inhibits the reaction [beta-Naphthoflavone results in increased activity of GSTA2 protein]; Mercury promotes the reaction [beta-Naphthoflavone results in increased expression of GSTA2 mRNA]
beta-Naphthoflavone results in increased expression of GSTA2 mRNA; beta-Naphthoflavone results in increased expression of GSTA3 protein
CTD PMID:2049074, PMID:9794803, PMID:12883083, PMID:15297030, PMID:15627257, PMID:19695238 NCBI chr 8:85,640,081...85,645,621 JBrowse link
G Gsta4 glutathione S-transferase alpha 4 increases expression EXP beta-Naphthoflavone results in increased expression of GSTA4 protein CTD PMID:9794803 NCBI chr 8:85,497,557...85,514,732
Ensembl chr 8:85,497,557...85,518,879
JBrowse link
G Gsta5 glutathione S-transferase alpha 5 multiple interactions
increases expression
EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA]
beta-Naphthoflavone results in increased expression of GSTA5 mRNA; beta-Naphthoflavone results in increased expression of GSTA5 protein
CTD PMID:9794803, PMID:18164116, PMID:19695238, PMID:20045035, PMID:22687991 NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
JBrowse link
G Gsta6 glutathione S-transferase alpha 6 increases expression
multiple interactions
increases activity
ISO beta-Naphthoflavone results in increased expression of GSTA1 protein; beta-Naphthoflavone results in increased expression of GSTA2 mRNA; beta-Naphthoflavone results in increased expression of GSTA2 protein
Copper inhibits the reaction [beta-Naphthoflavone results in increased expression of GSTA2 mRNA]; Copper promotes the reaction [beta-Naphthoflavone results in increased activity of GSTA2 protein]; Lead inhibits the reaction [beta-Naphthoflavone results in increased activity of GSTA2 protein]; Lead inhibits the reaction [beta-Naphthoflavone results in increased expression of GSTA2 mRNA]; Lipopolysaccharides inhibits the reaction [beta-Naphthoflavone results in increased expression of GSTA1 mRNA]; Mercury inhibits the reaction [beta-Naphthoflavone results in increased activity of GSTA2 protein]; Mercury promotes the reaction [beta-Naphthoflavone results in increased expression of GSTA2 mRNA]
CTD PMID:2049074, PMID:15297030, PMID:15627257 NCBI chr 9:27,475,273...27,533,939
Ensembl chr 9:27,475,273...27,511,176
JBrowse link
G Gstm1 glutathione S-transferase mu 1 increases expression
multiple interactions
ISO
EXP
beta-Naphthoflavone results in increased expression of GSTM1 mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA]
CTD PMID:18164116, PMID:18723825, PMID:20045035, PMID:22687991 NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
JBrowse link
G Gstm2 glutathione S-transferase mu 2 increases expression
multiple interactions
EXP
ISO
beta-Naphthoflavone results in increased expression of GSTM2 mRNA
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM2 mRNA
CTD PMID:19695238, PMID:19737545 NCBI chr 2:210,778,041...210,782,807
Ensembl chr 2:210,720,704...210,782,856
JBrowse link
G Gstm4 glutathione S-transferase mu 4 multiple interactions
increases expression
ISO
EXP
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM4 mRNA
beta-Naphthoflavone results in increased expression of GSTM4 mRNA
CTD PMID:19695238, PMID:19737545 NCBI chr 2:210,834,013...210,839,242
Ensembl chr 2:210,833,884...210,839,295
JBrowse link
G Gstm5 glutathione S-transferase, mu 5 multiple interactions
increases expression
ISO
EXP
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM3 mRNA
beta-Naphthoflavone results in increased expression of GSTM3 protein
CTD PMID:9794803, PMID:19737545 NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272
JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression EXP
ISO
beta-Naphthoflavone results in increased expression of GSTP1 mRNA; beta-Naphthoflavone results in increased expression of GSTP1 protein CTD PMID:9794803, PMID:19118567, PMID:19695238, PMID:23063670 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
JBrowse link
G Gucy2c guanylate cyclase 2C multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GUCY2C mRNA CTD PMID:18164116 NCBI chr 4:170,659,993...170,740,274
Ensembl chr 4:170,659,998...170,740,274
JBrowse link
G H1f2 H1.2 linker histone, cluster member increases expression ISO beta-Naphthoflavone results in increased expression of H1-2 mRNA CTD PMID:19737606 NCBI chr17:43,638,938...43,640,445
Ensembl chr17:43,639,749...43,640,387
JBrowse link
G H6pd hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) increases expression ISO beta-Naphthoflavone results in increased expression of H6PD mRNA CTD PMID:23994337 NCBI chr 5:166,994,683...167,030,441
Ensembl chr 5:166,998,881...167,030,441
JBrowse link
G Hagh hydroxyacyl glutathione hydrolase decreases expression
multiple interactions
ISO beta-Naphthoflavone results in decreased expression of HAGH mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of HAGH mRNA]
CTD PMID:22234961 NCBI chr10:14,215,913...14,230,506
Ensembl chr10:14,216,155...14,230,515
JBrowse link
G Hal histidine ammonia lyase multiple interactions
decreases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of HAL mRNA
beta-Naphthoflavone results in decreased expression of HAL mRNA
CTD PMID:18164116, PMID:23994337 NCBI chr 7:34,326,087...34,356,413
Ensembl chr 7:34,326,087...34,356,413
JBrowse link
G Hamp hepcidin antimicrobial peptide multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of HAMP mRNA CTD PMID:18164116 NCBI chr 1:89,368,021...89,369,960
Ensembl chr 1:89,368,021...89,369,960
JBrowse link
G Haus1 HAUS augmin-like complex, subunit 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HAUS1 mRNA CTD PMID:18164116 NCBI chr18:74,140,759...74,151,965
Ensembl chr18:74,187,162...74,198,369
JBrowse link
G Hbb hemoglobin subunit beta multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HBB mRNA CTD PMID:18164116 NCBI chr 1:168,971,269...168,972,680
Ensembl chr 1:168,971,274...168,972,725
JBrowse link
G Hcn4 hyperpolarization activated cyclic nucleotide-gated potassium channel 4 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HCN4 mRNA CTD PMID:18164116 NCBI chr 8:63,599,907...63,637,327
Ensembl chr 8:63,600,663...63,639,654
JBrowse link
G Hdac1 histone deacetylase 1 increases expression EXP beta-Naphthoflavone results in increased expression of HDAC1 protein CTD PMID:19389873 NCBI chr 5:147,716,664...147,743,723
Ensembl chr 5:147,716,664...147,743,723
JBrowse link
G Hdc histidine decarboxylase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of HDC mRNA CTD PMID:18164116 NCBI chr 3:119,057,524...119,075,599
Ensembl chr 3:119,057,517...119,075,619
JBrowse link
G Hivep2 HIVEP zinc finger 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HIVEP2 mRNA CTD PMID:18164116 NCBI chr 1:8,129,354...8,333,890
Ensembl chr 1:8,310,577...8,333,885
JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions
decreases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HMGCR mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of HMGCR mRNA]
CTD PMID:18164116, PMID:22234961, PMID:31225620 NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 decreases expression
multiple interactions
ISO beta-Naphthoflavone results in decreased expression of HMGCS1 mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of HMGCS1 mRNA]
CTD PMID:22234961 NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
ISO
EXP
[beta-Naphthoflavone co-treated with Copper] results in increased expression of HMOX1 mRNA; [beta-Naphthoflavone co-treated with Lead] results in increased expression of HMOX1 mRNA; [beta-Naphthoflavone co-treated with Mercury] results in increased expression of HMOX1 mRNA
beta-Naphthoflavone results in increased expression of HMOX1 mRNA
isoquercitrin inhibits the reaction [beta-Naphthoflavone results in increased expression of HMOX1 protein]
CTD PMID:15297030, PMID:15337587, PMID:19737606, PMID:21295105, PMID:22258563, PMID:32151702 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
JBrowse link
G Hoxa1 homeobox A1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HOXA1 mRNA CTD PMID:18164116 NCBI chr 4:82,124,358...82,127,182
Ensembl chr 4:82,125,406...82,127,066
JBrowse link
G Hp haptoglobin decreases expression
multiple interactions
ISO beta-Naphthoflavone results in decreased expression of HP mRNA
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of HP mRNA
CTD PMID:19737545, PMID:19737606 NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase multiple interactions ISO
EXP
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of HPGD mRNA
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of HPGD mRNA
CTD PMID:18164116, PMID:19737545 NCBI chr16:37,457,134...37,495,758
Ensembl chr16:37,457,135...37,495,758
JBrowse link
G Hpx hemopexin decreases expression ISO beta-Naphthoflavone results in decreased expression of HPX mRNA CTD PMID:19737606 NCBI chr 1:170,423,558...170,431,066
Ensembl chr 1:170,423,483...170,431,073
JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HSD17B2 mRNA CTD PMID:18164116 NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891
JBrowse link
G Hsd17b6 hydroxysteroid (17-beta) dehydrogenase 6 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of HSD17B6 mRNA CTD PMID:18164116 NCBI chr 7:2,412,370...2,431,249
Ensembl chr 7:2,412,363...2,431,197
Ensembl chr13:2,412,363...2,431,197
JBrowse link
G Hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 decreases expression
multiple interactions
ISO beta-Naphthoflavone results in decreased expression of HSD17B7 mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of HSD17B7 mRNA]
CTD PMID:22234961 NCBI chr13:88,288,116...88,308,019
Ensembl chr13:88,288,046...88,307,988
JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 increases expression ISO beta-Naphthoflavone results in increased expression of HSP90AB1 mRNA CTD PMID:32151702 NCBI chr 9:17,817,791...17,823,163
Ensembl chr 9:17,817,721...17,823,243
JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HSPA1A mRNA CTD PMID:18164116 NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779
JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B increases expression ISO beta-Naphthoflavone results in increased expression of HSPA1B mRNA CTD PMID:19737606 NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like increases expression ISO beta-Naphthoflavone results in increased expression of HSPA4L mRNA CTD PMID:23994337 NCBI chr 2:127,625,737...127,682,864
Ensembl chr 2:127,625,683...127,677,503
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression ISO beta-Naphthoflavone results in increased expression of HSPA5 mRNA CTD PMID:19737606 NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
JBrowse link
G Hspb2 heat shock protein family B (small) member 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HSPB2 mRNA CTD PMID:18164116 NCBI chr 8:55,176,648...55,178,227
Ensembl chr 8:55,176,847...55,177,818
JBrowse link
G Hspb8 heat shock protein family B (small) member 8 increases expression ISO beta-Naphthoflavone results in increased expression of HSPB8 mRNA CTD PMID:19737606 NCBI chr12:45,905,371...45,920,014
Ensembl chr12:45,905,371...45,920,013
JBrowse link
G Ica1 islet cell autoantigen 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ICA1 mRNA CTD PMID:18164116 NCBI chr 4:34,635,509...34,780,187
Ensembl chr 4:34,635,506...34,780,193
JBrowse link
G Id1 inhibitor of DNA binding 1, HLH protein decreases expression ISO beta-Naphthoflavone results in decreased expression of ID1 mRNA CTD PMID:23994337 NCBI chr 3:148,214,623...148,216,715
Ensembl chr 3:148,215,540...148,216,718
JBrowse link
G Id4 inhibitor of DNA binding 4, HLH protein multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ID4 mRNA CTD PMID:18164116 NCBI chr17:16,692,557...16,695,126
Ensembl chr17:16,692,557...16,695,126
JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 multiple interactions
decreases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of IDI1 mRNA
beta-Naphthoflavone results in decreased expression of IDI1 mRNA
AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of IDI1 mRNA]
CTD PMID:18164116, PMID:22234961, PMID:31225620 NCBI chr17:57,976,266...57,984,036
Ensembl chr17:57,976,268...57,984,036
JBrowse link
G Ier3 immediate early response 3 increases expression ISO beta-Naphthoflavone results in increased expression of IER3 mRNA CTD PMID:32151702 NCBI chr20:3,438,798...3,440,002
Ensembl chr20:3,438,798...3,440,769
JBrowse link
G Ier5 immediate early response 5 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IER5 mRNA CTD PMID:18164116 NCBI chr13:72,742,210...72,744,302
Ensembl chr13:72,742,210...72,744,303
JBrowse link
G Igdcc4 immunoglobulin superfamily, DCC subclass, member 4 decreases expression ISO beta-Naphthoflavone results in decreased expression of IGDCC4 mRNA CTD PMID:19737606 NCBI chr 8:70,591,561...70,627,329
Ensembl chr 8:70,603,249...70,624,925
JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IGF1 mRNA CTD PMID:18164116 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 increases expression ISO beta-Naphthoflavone results in increased expression of IGFBP1 mRNA CTD PMID:19737606 NCBI chr14:87,448,716...87,453,783
Ensembl chr14:87,448,692...87,453,785
JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IGFBP2 mRNA CTD PMID:18164116 NCBI chr 9:80,118,029...80,144,804
Ensembl chr 9:80,118,029...80,144,789
JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 increases expression ISO beta-Naphthoflavone results in increased expression of IGFBP3 mRNA CTD PMID:32151702 NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
JBrowse link
G Ihh Indian hedgehog signaling molecule multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of IHH mRNA CTD PMID:18164116 NCBI chr 9:82,208,223...82,214,440
Ensembl chr 9:82,208,223...82,214,440
JBrowse link
G Ikbke inhibitor of nuclear factor kappa B kinase subunit epsilon multiple interactions ISO [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of IKBKE mRNA CTD PMID:19737545 NCBI chr13:48,031,325...48,056,394
Ensembl chr13:48,031,410...48,056,394
JBrowse link
G Il11 interleukin 11 increases expression ISO beta-Naphthoflavone results in increased expression of IL11 mRNA CTD PMID:32151702 NCBI chr 1:72,636,959...72,643,255
Ensembl chr 1:72,635,267...72,643,255
JBrowse link
G Il12a interleukin 12A multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IL12A mRNA CTD PMID:18164116 NCBI chr 2:165,076,945...165,083,996
Ensembl chr 2:165,076,607...165,084,318
JBrowse link
G Il13 interleukin 13 multiple interactions ISO beta-Naphthoflavone promotes the reaction [Plant Extracts results in increased expression of IL13 protein] CTD PMID:22491429 NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
JBrowse link
G Il17a interleukin 17A multiple interactions ISO beta-Naphthoflavone promotes the reaction [Plant Extracts results in increased expression of IL17A protein] CTD PMID:22491429 NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
JBrowse link
G Il1a interleukin 1 alpha increases expression
multiple interactions
ISO
EXP
beta-Naphthoflavone results in increased expression of IL1A mRNA
[isoquercitrin co-treated with Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IL1A mRNA
CTD PMID:8156173, PMID:21295105, PMID:32151702 NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
JBrowse link
G Il1b interleukin 1 beta decreases expression
increases expression
multiple interactions
ISO beta-Naphthoflavone results in decreased expression of IL1B mRNA
beta-Naphthoflavone results in increased expression of IL1B mRNA
IL1B protein promotes the reaction [beta-Naphthoflavone results in increased expression of CXCL5 mRNA]
CTD PMID:8156173, PMID:28973351, PMID:32151702 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
JBrowse link
G Il1r1 interleukin 1 receptor type 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of IL1R1 mRNA CTD PMID:18164116 NCBI chr 9:46,962,291...47,038,139
Ensembl chr 9:46,962,288...47,036,670
JBrowse link
G Il1r2 interleukin 1 receptor type 2 increases expression ISO beta-Naphthoflavone results in increased expression of IL1R2 mRNA CTD PMID:32151702 NCBI chr 9:46,840,646...46,881,241
Ensembl chr 9:46,840,992...46,881,264
JBrowse link
G Il1rn interleukin 1 receptor antagonist increases expression ISO beta-Naphthoflavone results in increased expression of IL1RN mRNA CTD PMID:32151702 NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
JBrowse link
G Il20 interleukin 20 increases expression ISO beta-Naphthoflavone results in increased expression of IL20 mRNA CTD PMID:32151702 NCBI chr13:47,644,071...47,651,487
Ensembl chr13:47,644,071...47,647,715
JBrowse link
G Il22 interleukin 22 increases expression ISO beta-Naphthoflavone results in increased expression of IL22 mRNA CTD PMID:25716673 NCBI chr 7:61,236,037...61,240,502
Ensembl chr 7:61,236,037...61,240,502
JBrowse link
G Il23a interleukin 23 subunit alpha increases expression ISO beta-Naphthoflavone results in increased expression of IL23A mRNA CTD PMID:32151702 NCBI chr 7:2,710,609...2,712,723
Ensembl chr 7:2,710,609...2,712,723
JBrowse link
G Il24 interleukin 24 increases expression ISO beta-Naphthoflavone results in increased expression of IL24 mRNA CTD PMID:32151702 NCBI chr13:47,618,451...47,623,849
Ensembl chr13:47,618,452...47,623,849
JBrowse link
G Il2rb interleukin 2 receptor subunit beta multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of IL2RB mRNA CTD PMID:18164116 NCBI chr 7:119,701,338...119,716,238
Ensembl chr 7:119,701,251...119,716,238
JBrowse link
G Il36g interleukin 36, gamma increases expression ISO beta-Naphthoflavone results in increased expression of IL36G mRNA CTD PMID:32151702 NCBI chr 3:1,285,658...1,291,836
Ensembl chr 3:1,285,664...1,291,865
JBrowse link
G Il5 interleukin 5 multiple interactions ISO beta-Naphthoflavone promotes the reaction [Plant Extracts results in increased expression of IL5 protein] CTD PMID:22491429 NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of IL6 mRNA
beta-Naphthoflavone results in increased expression of IL6 mRNA
CTD PMID:8156173, PMID:21295105, PMID:32151702 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Inhbb inhibin subunit beta B multiple interactions
decreases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of INHBB mRNA
beta-Naphthoflavone results in decreased expression of INHBB mRNA
CTD PMID:18164116, PMID:19737606 NCBI chr13:35,436,532...35,442,222
Ensembl chr13:35,436,532...35,442,222
JBrowse link
G Inhbe inhibin subunit beta E increases expression ISO beta-Naphthoflavone results in increased expression of INHBE mRNA CTD PMID:17175557 NCBI chr 7:70,641,423...70,642,848
Ensembl chr 7:70,640,075...70,643,169
JBrowse link
G Insig2 insulin induced gene 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of INSIG2 mRNA CTD PMID:18164116 NCBI chr13:37,264,818...37,292,718
Ensembl chr13:37,266,312...37,287,458
JBrowse link
G Irak2 interleukin-1 receptor-associated kinase 2 increases expression ISO beta-Naphthoflavone results in increased expression of IRAK2 mRNA CTD PMID:32151702 NCBI chr 4:145,594,575...145,651,066
Ensembl chr 4:145,594,575...145,651,053
JBrowse link
G Irf1 interferon regulatory factor 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IRF1 mRNA CTD PMID:18164116 NCBI chr10:39,109,530...39,116,532
Ensembl chr10:39,109,522...39,116,531
JBrowse link
G Irf7 interferon regulatory factor 7 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of IRF7 mRNA CTD PMID:18164116 NCBI chr 1:214,249,388...214,252,909
Ensembl chr 1:214,248,837...214,252,456
JBrowse link
G Irgm immunity-related GTPase M multiple interactions
decreases expression
ISO AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of IRGM mRNA] CTD PMID:22234961 NCBI chr10:34,213,885...34,221,968
Ensembl chr10:34,213,936...34,221,928
JBrowse link
G Irs2 insulin receptor substrate 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IRS2 mRNA CTD PMID:18164116 NCBI chr16:83,824,515...83,848,569
Ensembl chr16:83,824,430...83,848,684
JBrowse link
G Isg20 interferon stimulated exonuclease gene 20 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ISG20 mRNA CTD PMID:18164116 NCBI chr 1:140,602,553...140,608,892
Ensembl chr 1:140,601,791...140,608,946
JBrowse link
G Itga8 integrin subunit alpha 8 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ITGA8 mRNA CTD PMID:18164116 NCBI chr17:79,321,893...79,676,927
Ensembl chr17:79,321,900...79,676,499
JBrowse link
G Itgb6 integrin subunit beta 6 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ITGB6 mRNA CTD PMID:18164116 NCBI chr 3:46,652,624...46,775,362
Ensembl chr 3:46,652,623...46,726,958
JBrowse link
G Itpkb inositol-trisphosphate 3-kinase B multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ITPKB mRNA; [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ITPKB mRNA CTD PMID:18164116 NCBI chr13:98,615,287...98,710,426
Ensembl chr13:98,615,287...98,708,149
JBrowse link
G Ivl involucrin increases expression ISO beta-Naphthoflavone results in increased expression of IVL mRNA CTD PMID:32151702 NCBI chr 2:192,761,171...192,773,346
Ensembl chr 2:192,761,538...192,763,577
JBrowse link
G Jam2 junctional adhesion molecule 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of JAM2 mRNA CTD PMID:18164116 NCBI chr11:24,235,310...24,285,279
Ensembl chr11:24,266,345...24,285,275
JBrowse link
G Josd1 Josephin domain containing 1 increases expression ISO beta-Naphthoflavone results in increased expression of JOSD1 mRNA CTD PMID:23994337 NCBI chr 7:120,905,343...120,919,261
Ensembl chr 7:120,905,337...120,919,261
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO beta-Naphthoflavone promotes the reaction [JUN protein binds to NQO1 promoter] CTD PMID:8375015 NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit increases expression ISO beta-Naphthoflavone results in increased expression of JUNB mRNA CTD PMID:32151702 NCBI chr19:26,092,972...26,094,756
Ensembl chr19:26,092,974...26,094,756
JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit increases expression ISO beta-Naphthoflavone results in increased expression of JUND mRNA CTD PMID:32151702 NCBI chr16:20,485,028...20,486,707
Ensembl chr16:20,485,029...20,486,707
JBrowse link
G Kalrn kalirin, RhoGEF kinase multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KALRN mRNA CTD PMID:18164116 NCBI chr11:69,484,293...70,025,682
Ensembl chr11:69,484,293...70,025,633
JBrowse link
G Kank1 KN motif and ankyrin repeat domains 1 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of KANK1 mRNA CTD PMID:18164116 NCBI chr 1:243,201,073...243,398,531
Ensembl chr 1:243,276,403...243,398,536
JBrowse link
G Kcna2 potassium voltage-gated channel subfamily A member 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KCNA2 mRNA CTD PMID:18164116 NCBI chr 2:209,838,607...209,852,471
Ensembl chr 2:209,838,869...209,852,471
JBrowse link
G Kcnt2 potassium sodium-activated channel subfamily T member 2 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of KCNT2 mRNA CTD PMID:18164116 NCBI chr13:57,130,855...57,520,263
Ensembl chr13:57,131,395...57,521,836
JBrowse link
G Kif12 kinesin family member 12 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KIF12 mRNA CTD PMID:18164116 NCBI chr 5:79,001,708...79,008,370
Ensembl chr 5:79,001,459...79,008,363
JBrowse link
G Kif22 kinesin family member 22 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KIF22 mRNA CTD PMID:18164116 NCBI chr 1:198,461,406...198,476,430
Ensembl chr 1:198,461,169...198,476,476
JBrowse link
G Kif4a kinesin family member 4A multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KIF4 mRNA CTD PMID:18164116 NCBI chr  X:70,461,700...70,561,084
Ensembl chr  X:70,461,718...70,561,189
JBrowse link
G Klf6 Kruppel-like factor 6 increases expression ISO beta-Naphthoflavone results in increased expression of KLF6 mRNA CTD PMID:19737606 NCBI chr17:67,887,939...67,945,052
Ensembl chr17:67,887,939...67,945,037
JBrowse link
G Klk14 kallikrein related-peptidase 14 increases expression ISO beta-Naphthoflavone results in increased expression of KLK14 mRNA CTD PMID:19737606 NCBI chr 1:99,616,153...99,621,425
Ensembl chr 1:99,616,447...99,621,037
JBrowse link
G Klrg1 killer cell lectin like receptor G1 increases expression ISO beta-Naphthoflavone results in increased expression of KLRG1 mRNA CTD PMID:19737606 NCBI chr 4:155,038,936...155,051,449
Ensembl chr 4:155,039,628...155,051,429
JBrowse link
G Knstrn kinetochore-localized astrin/SPAG5 binding protein multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KNSTRN mRNA CTD PMID:18164116 NCBI chr 3:110,618,256...110,638,024
Ensembl chr 3:110,618,298...110,638,046
JBrowse link
G Kpna6 karyopherin subunit alpha 6 increases expression ISO beta-Naphthoflavone results in increased expression of KPNA6 mRNA CTD PMID:23994337 NCBI chr 5:147,852,738...147,867,600
Ensembl chr 5:147,850,275...147,886,615
JBrowse link
G Krt1 keratin 1 affects expression ISO beta-Naphthoflavone affects the expression of KRT1 mRNA CTD PMID:32151702 NCBI chr 7:143,448,318...143,453,544
Ensembl chr 7:143,448,318...143,453,544
JBrowse link
G Krt10 keratin 10 decreases expression ISO beta-Naphthoflavone results in decreased expression of KRT10 mRNA CTD PMID:16985168 NCBI chr10:87,296,445...87,301,307
Ensembl chr10:87,296,451...87,300,736
JBrowse link
G Krt13 keratin 13 increases expression ISO beta-Naphthoflavone results in increased expression of KRT13 mRNA CTD PMID:32151702 NCBI chr10:88,032,130...88,036,040
Ensembl chr10:88,032,130...88,036,040
JBrowse link
G Krt14 keratin 14 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of KRT14 mRNA CTD PMID:18164116 NCBI chr10:88,118,029...88,122,233
Ensembl chr10:88,055,823...88,122,233
JBrowse link
G Krt19 keratin 19 multiple interactions
increases expression
EXP
ISO
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KRT19 mRNA
beta-Naphthoflavone results in increased expression of KRT19 mRNA
CTD PMID:18164116, PMID:32151702 NCBI chr10:88,055,843...88,060,560
Ensembl chr10:88,055,841...88,060,561
JBrowse link
G Krt20 keratin 20 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KRT20 mRNA CTD PMID:18164116 NCBI chr10:87,342,514...87,351,045
Ensembl chr10:87,342,619...87,351,045
JBrowse link
G Krt23 keratin 23 multiple interactions EXP [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of KRT23 mRNA CTD PMID:18164116 NCBI chr10:87,391,623...87,407,634
Ensembl chr10:87,391,623...87,407,634
JBrowse link
G Krt31 keratin 31 increases expression ISO beta-Naphthoflavone results in increased expression of KRT31 mRNA CTD PMID:32151702 NCBI chr10:87,959,123...87,962,891
Ensembl chr10:87,959,408...87,962,846
JBrowse link
G Krt34 keratin 34 increases expression ISO